Sequential Brands (SQBG) 10-Q 12 Nov 19 2019 Q3 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	9 Months Ended
	Sep. 30, 2019	Nov. 01, 2019
Document And Entity Information [Abstract]
Document Type	10-Q
Document Period End Date	Sep. 30, 2019
Entity Registrant Name	Sequential Brands Group, Inc.
Entity Current Reporting Status	Yes
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		65,514,936
Entity Central Index Key	0001648428
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q3
Amendment Flag	false

CONDENSED CONSOLIDATED BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Current Assets:
Cash	$ 3,097	$ 14,106
Restricted cash	2,039	2,032
Accounts receivable, net	41,409	49,600
Prepaid expenses and other current assets	5,456	3,981
Current assets held for disposition from discontinued operations	9,218	23,845
Total current assets	61,219	93,564
Property and equipment, net	7,294	8,391
Intangible assets, net	600,394	634,827
Right-of-use assets - operating leases	48,237
Other assets	9,713	11,222
Long-term assets held for disposition from discontinued operations		330,664
Total assets	726,857	1,078,668
Current Liabilities:
Accounts payable and accrued expenses	11,277	11,600
Current portion of long-term debt	21,000	28,300
Current portion of deferred revenue	7,629	8,172
Current portion of lease liabilities - operating leases	2,869
Current liabilities held for disposition from discontinued operations	3,731	15,450
Total current liabilities	46,506	63,522
Long-term debt, net of current portion	418,081	582,487
Long-term deferred revenue, net of current portion	5,509	8,224
Deferred income taxes	15,438	32,064
Lease liabilities - operating leases	52,285
Other long-term liabilities	5,567	9,160
Long-term liabilities held for disposition from discontinued operations		38,567
Total liabilities	543,386	734,024
Commitments and contingencies
Equity:
Preferred stock Series A, $0.01 par value; 10,000,000 shares authorized; none issued and outstanding at September 30, 2019 and December 31, 2018
Common stock, $0.01 par value; 150,000,000 shares authorized; 66,854,432 and 65,990,179 shares issued at September 30, 2019 and December 31, 2018, respectively, and 65,427,951 and 64,327,582 shares outstanding at September 30, 2019 and December 31, 2018, respectively	668	657
Additional paid-in capital	514,072	513,764
Accumulated other comprehensive loss	(4,640)	(1,554)
Accumulated deficit	(383,347)	(234,723)
Treasury stock, at cost; 1,426,481 and 1,662,597 shares at September 30, 2019 and December 31, 2018, respectively	(3,350)	(4,226)
Total Sequential Brands Group, Inc. and Subsidiaries stockholders' equity	123,403	273,918
Noncontrolling interest	60,068	70,726
Total equity	183,471	344,644
Total liabilities and equity	$ 726,857	$ 1,078,668

CONDENSED CONSOLIDATED BALANC_2

CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Sep. 30, 2019	Dec. 31, 2018
Statement Of Financial Position [Abstract]
Preferred stock Series A, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock Series A, shares authorized	10,000,000	10,000,000
Preferred stock Series A, shares issued	0	0
Preferred stock Series A, shares outstanding	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	66,854,432	65,990,179
Common stock, shares outstanding	65,427,951	64,327,582
Treasury stock, shares	1,426,481	1,662,597

CONDENSED CONSOLIDATED STATEMEN

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Income Statement [Abstract]
Net revenue	$ 25,392	$ 29,455	$ 77,331	$ 92,044
Operating expenses	12,247	15,414	41,700	41,979
Impairment charges	33,109	17,899	33,109	17,899
Loss on sale of assets				7,117
(Loss) income from operations	(19,964)	(3,858)	2,522	25,049
Other expense (income)	(843)	31	(1,270)	135
Interest expense, net	13,048	13,862	40,794	41,609
(Loss) income from continuing operations before income taxes	(33,855)	(17,689)	(39,542)	(16,425)
Benefit for income taxes	(6,035)	(8,808)	(6,655)	(9,289)
Loss from continuing operations	(27,820)	(8,881)	(32,887)	(7,136)
Net loss (income) attributable to noncontrolling interests from continuing operations	9,449	(1,581)	6,455	(4,643)
Loss from continuing operations attributable to Sequential Brands Group, Inc. and Subsidiaries	(18,371)	(10,462)	(26,432)	(11,779)
(Loss) income from discontinued operations, net of income taxes	(309)	847	(122,192)	3,487
Net loss attributable to Sequential Brands Group, Inc. and Subsidiaries	$ (18,680)	$ (9,615)	$ (148,624)	$ (8,292)
(Loss) earnings per share - basic:
Continuing operations	$ (0.28)	$ (0.16)	$ (0.41)	$ (0.19)
Discontinued operations	0	0.01	(1.89)	0.05
(Loss) earnings per share - diluted:
Discontinued operations	0	0.01	(1.89)	0.05
(Loss) earnings per share attributable to Sequential Brands Group, Inc. and Subsidiaries:
Basic and diluted (in dollars per share)	$ (0.29)	$ (0.15)	$ (2.30)	$ (0.13)
Weighted-average common shares outstanding:
Basic (in shares)	64,952,093	63,911,481	64,622,332	63,578,121
Diluted (in shares)	64,952,093	64,270,995	64,622,332	64,622,891

CONDENSED CONSOLIDATED STATEM_2

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Thousands	Total Sequential Brands Group, Inc. and Subsidiaries Stockholders' Equity	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Other Comprehensive Loss [Member]	Accumulated Deficit [Member]	Treasury Stock [Member]	Noncontrolling Interest [Member]	Total
Balance at Dec. 31, 2017	$ 281,991	$ 635	$ 508,444	$ 80	$ (225,369)		$ 71,547	$ 353,538
Balance (in shares) at Dec. 31, 2017		63,652,721
Treasury stock at Dec. 31, 2017						$ (1,799)
Treasury stock, shares at Dec. 31, 2017						(424,994)
Stock-based compensation	1,345	$ 2	1,343					1,345
Stock-based compensation (in shares)		452,929
Shares issued under stock incentive plan	1,500	$ 8	1,492					1,500
Shares issued under stock incentive plan (in shares)		843,486
Unrealized gain (loss) on interest rate caps, net of tax	679			679				679
Repurchase of common stock	(1,919)					$ (1,919)		(1,919)
Repurchase of common stock (in shares)						(986,858)
Noncontrolling interest distribution							(1,244)	(1,244)
Net income (loss) attributable to noncontrolling interest							1,960	1,960
Net income (loss) attributable to common stockholders	(2,264)				(2,264)			(2,264)
Treasury stock at Mar. 31, 2018						$ (3,718)
Treasury stock, shares at Mar. 31, 2018						(1,411,852)
Balance at Mar. 31, 2018	282,462	$ 645	511,279	759	(226,503)		72,618	355,080
Balance (in shares) at Mar. 31, 2018		64,949,136
Balance at Dec. 31, 2017	281,991	$ 635	508,444	80	(225,369)		71,547	353,538
Balance (in shares) at Dec. 31, 2017		63,652,721
Treasury stock at Dec. 31, 2017						$ (1,799)
Treasury stock, shares at Dec. 31, 2017						(424,994)
Treasury stock at Sep. 30, 2018						$ (4,217)
Treasury stock, shares at Sep. 30, 2018						(1,657,217)
Balance at Sep. 30, 2018	277,280	$ 656	513,439	(67)	(232,531)		71,220	348,500
Balance (in shares) at Sep. 30, 2018		65,934,552
Cumulative effect of revenue recognition accounting change	1,130				1,130		355	1,485
Balance at Mar. 31, 2018	282,462	$ 645	511,279	759	(226,503)		72,618	355,080
Balance (in shares) at Mar. 31, 2018		64,949,136
Treasury stock at Mar. 31, 2018						$ (3,718)
Treasury stock, shares at Mar. 31, 2018						(1,411,852)
Stock-based compensation	770	$ 6	764					770
Stock-based compensation (in shares)		420,770
Unrealized loss on equity securities	(228)			(228)				(228)
Unrealized gain (loss) on interest rate caps, net of tax	(238)			(238)				(238)
Repurchase of common stock	(83)					$ (83)		(83)
Repurchase of common stock (in shares)						(42,669)
Noncontrolling interest distribution							(2,943)	(2,943)
Net income (loss) attributable to noncontrolling interest							1,102	1,102
Net income (loss) attributable to common stockholders	3,587				3,587			3,587
Treasury stock at Jun. 30, 2018						$ (3,801)
Treasury stock, shares at Jun. 30, 2018						(1,454,521)
Balance at Jun. 30, 2018	286,270	$ 651	512,043	293	(222,916)		70,777	357,047
Balance (in shares) at Jun. 30, 2018		65,369,906
Stock-based compensation	1,401	$ 5	1,396					1,401
Stock-based compensation (in shares)		564,646
Unrealized loss on equity securities	(49)			(49)				(49)
Unrealized gain (loss) on interest rate caps, net of tax	(311)			(311)				(311)
Repurchase of common stock	(416)					$ (416)		(416)
Repurchase of common stock (in shares)						(202,696)
Noncontrolling interest distribution							(1,138)	(1,138)
Net income (loss) attributable to noncontrolling interest							1,581	1,581
Net income (loss) attributable to common stockholders	(9,615)				(9,615)			(9,615)
Treasury stock at Sep. 30, 2018						$ (4,217)
Treasury stock, shares at Sep. 30, 2018						(1,657,217)
Balance at Sep. 30, 2018	277,280	$ 656	513,439	(67)	(232,531)		71,220	348,500
Balance (in shares) at Sep. 30, 2018		65,934,552
Balance at Dec. 31, 2018	273,918	$ 657	513,764	(1,554)	(234,723)		70,726	344,644
Balance (in shares) at Dec. 31, 2018		65,990,179
Treasury stock at Dec. 31, 2018						$ (4,226)		$ (4,226)
Treasury stock, shares at Dec. 31, 2018						(1,662,597)		(1,662,597)
Stock-based compensation	726	$ 5	721					$ 726
Stock-based compensation (in shares)		457,734
Unrealized gain (loss) on interest rate caps, net of tax	(1,480)			(1,480)				(1,480)
Repurchase of common stock	(170)					$ (170)		(170)
Repurchase of common stock (in shares)						(134,839)
Noncontrolling interest distribution							(1,093)	(1,093)
Net income (loss) attributable to noncontrolling interest							1,539	1,539
Net income (loss) attributable to common stockholders	(125,345)				(125,345)			(125,345)
Treasury stock at Mar. 31, 2019						$ (4,396)
Treasury stock, shares at Mar. 31, 2019						(1,797,436)
Balance at Mar. 31, 2019	147,649	$ 662	514,485	(3,034)	(360,068)		71,172	218,821
Balance (in shares) at Mar. 31, 2019		66,447,913
Stock-based compensation	567	$ 6	561					567
Stock-based compensation (in shares)		383,456
Shares issued from treasury stock			(1,124)			$ 1,124
Shares issued from treasury stock (in shares						464,576
Unrealized gain (loss) on interest rate caps, net of tax	(1,684)			(1,684)				(1,684)
Repurchase of common stock	(78)					$ (78)		(78)
Repurchase of common stock (in shares)						(93,621)
Noncontrolling interest distribution							(2,046)	(2,046)
Net income (loss) attributable to noncontrolling interest							1,455	1,455
Net income (loss) attributable to common stockholders	(4,599)				(4,599)			(4,599)
Treasury stock at Jun. 30, 2019						$ (3,350)
Treasury stock, shares at Jun. 30, 2019						(1,426,481)
Balance at Jun. 30, 2019	141,855	$ 668	513,922	(4,718)	(364,667)		70,581	212,436
Balance (in shares) at Jun. 30, 2019		66,831,369
Stock-based compensation	150		150					150
Stock-based compensation (in shares)		23,063
Unrealized gain (loss) on interest rate caps, net of tax	78			78				78
Noncontrolling interest distribution							(1,064)	(1,064)
Net income (loss) attributable to noncontrolling interest							(9,449)	(9,449)
Net income (loss) attributable to common stockholders	(18,680)				(18,680)			(18,680)
Treasury stock at Sep. 30, 2019						$ (3,350)		$ (3,350)
Treasury stock, shares at Sep. 30, 2019						(1,426,481)		(1,426,481)
Balance at Sep. 30, 2019	$ 123,403	$ 668	$ 514,072	$ (4,640)	$ (383,347)		$ 60,068	$ 183,471
Balance (in shares) at Sep. 30, 2019		66,854,432

CONDENSED CONSOLIDATED STATEM_3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018	Sep. 30, 2019	Dec. 31, 2018	Sep. 30, 2018
Cash flows from operating activities
Loss from continuing operations			$ (32,887)	$ (7,136)
(Loss) income from discontinued operations, net of tax	$ (309)	$ 847	(122,192)	3,487
(Loss) income from continuing operations, net of tax	(27,820)	(8,881)	(32,887)	(7,136)
Adjustments to reconcile loss income to net cash (used in) provided by operating activities:
Provision for bad debts			2,812	30
Depreciation and amortization			2,586	1,817
Stock-based compensation			1,299	2,699
Amortization of operating leases			4,705	3,145
Loss on debt extinguishment				148
Impairment charges			33,109	17,899
Loss (income) from equity method investment			25	(31)
Loss on interest rate swaps			1,276
Loss on equity securities	400	0	85	0
Amortization of ROU assets and accretion of lease liabilities - operating leases			4,648
Loss on sale of assets				7,117
Deferred income taxes			(16,626)	(6,845)
Changes in operating assets and liabilities:
Accounts receivable			5,379	2,722
Prepaid expenses and other assets			(76)	(7,308)
Accounts payable and accrued expenses			(1,616)	(1,848)
Deferred revenue			(3,258)	(5,190)
Other liabilities			(4,410)	8,180
Cash (used in) provided by operating activities from continuing operations			(2,949)	15,399
Cash provided by operating activities from discontinued operations			7,647	4,711
Cash provided by operating activities			4,698	20,110
Cash flows from investing activities
Investments in intangible assets, including registration and renewal costs			(100)	(179)
Purchases of property and equipment			(48)	(4,040)
Proceeds from sale of trademark				4,356
Proceeds from sale of discontinued operations			165,928
Cash provided by investing activities from continuing operations			165,780	137
Cash used in investing activities from discontinued operations			(44)	(44)
Cash provided by investing activities			165,736	93
Cash flows from financing activities
Proceeds from long-term debt				107,607
Payment of long-term debt			(173,161)	(110,381)
Guaranteed payments in connection with acquisitions				(475)
Deferred financing costs			(3,250)	(14,590)
Repurchases of common stock			(248)	(2,418)
Noncontrolling interest distributions			(4,203)	(5,325)
Cash used in financing activities from continuing operations			(180,862)	(25,582)
Cash used in financing activities from discontinued operations			(574)	(975)
Cash used in financing activities			(181,436)	(26,557)
Net decrease in cash and restricted cash			(11,002)	(6,354)
Balance — Beginning of period			16,138	20,433	$ 20,433
Balance — End of period	5,136	14,079	5,136	14,079	16,138
Reconciliation to amounts on condensed consolidated balance sheets
Cash						$ 3,097	$ 14,106	$ 12,052
Restricted cash						2,039	2,032	2,027
Total cash and restricted cash	$ 5,136	$ 14,079	16,138	20,433	$ 20,433	$ 5,136	$ 16,138	$ 14,079
Supplemental disclosures of cash flow information
Cash paid for: Interest			41,331	44,173
Cash paid for: Taxes			89	74
Non-cash investing and financing activities
Accrued purchases of property and equipment at year end			17	26
Unrealized gain on equity securities during the year				277
Unrealized (loss) gain on interest rate cap, net during the period				$ 130
Unrealize loss on interest rate swaps, net during the period			$ (3,086)

Organization and Nature of Oper

Organization and Nature of Operations	9 Months Ended
	Sep. 30, 2019
Organization and Nature of Operations [Abstract]
Organization and Nature of Operations	1. Organization and Nature of Operations Overview Sequential Brands Group, Inc. (the “Company”) owns a portfolio of consumer brands in the active and lifestyle categories. The Company aims to maximize the strategic value of its brands by promoting, marketing and licensing its global brands through various distribution channels, including to retailers, wholesalers and distributors in the United States and in certain international territories. The Company’s core strategy is to enhance and monetize the global reach of its existing brands, and to pursue additional strategic acquisitions to grow the scope of and diversify its portfolio of brands. The Company licenses brands to both wholesale and direct-to-retail licensees. In a wholesale license, a wholesale supplier is granted rights (typically on an exclusive basis) to a single or small group of related product categories for a particular brand for sale to multiple accounts within an approved channel of distribution and territory. In a direct-to-retail license, a single retailer is granted the right (typically on an exclusive basis) to sell branded products in a broad range of product categories through its brick and mortar stores and e-commerce sites. As of September 30, 2019, the Company had approximately one-hundred licensees, with wholesale licensees comprising a significant majority.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2019
Summary of Significant Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10‑Q and Rule 10‑01 of Regulation S-X of the United States Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all of the information and footnotes necessary for a comprehensive presentation of financial position, results of operations or cash flows. It is the Company’s opinion, however, that the accompanying unaudited condensed consolidated financial statements include all adjustments, which are of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10‑K for the year ended December 31, 2018, as filed with the SEC on March 14, 2019, which contains the audited consolidated financial statements and notes thereto, together with Management’s Discussion and Analysis of Financial Condition and Results of Operations, for the years ended December 31, 2018, 2017 and 2016. The financial information as of December 31, 2018 is derived from the audited consolidated financial statements presented in the Company’s Annual Report on Form 10‑K for the year ended December 31, 2018. The interim results for September 30, 2019 are not necessarily indicative of the results to be expected for the year ending December 31, 2019 or for any future interim periods. Reclassification of Prior Periods On June 10, 2019, the Company completed the sale of Martha Stewart Living Omnimedia, Inc. (“MSLO”), a Delaware corporation and a wholly-owned subsidiary of the Company, for $166 million in cash consideration, plus additional amounts in respect of pre-closing accounts receivable that are received after the closing, subject to certain adjustments, pursuant to an equity purchase agreement (the “Purchase Agreement”) with Marquee Brands LLC (the “Buyer”) entered into on April 16, 2019. In addition, the Purchase Agreement provides for an earnout of up to $40,000,000 if certain performance targets are achieved during the three calendar years ending December 31, 2020, December 31, 2021 and December 31, 2022. MSLO and its subsidiaries were engaged in the business of promoting, marketing and licensing the Martha Stewart and the Emeril Lagasse brands through various distribution channels. Due to the sale of MSLO during the second quarter of 2019 (see Note 3), in accordance with Accounting Standards Codification (“ASC”) 205, Discontinued Operations , we have classified the results of MSLO as discontinued operations in our unaudited condensed consolidated statements of operations and cash flows for all periods presented. Additionally, the related assets and liabilities directly associated with MSLO are classified as held for disposition from discontinued operations in our condensed consolidated balance sheets for all periods presented. All amounts included in the notes to the condensed consolidated financial statements relate to continuing operations unless otherwise noted. Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation. Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates. Revenue Recognition The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers (“ASC 606”), which became effective for the Company as of January 1, 2018. ASC 606 requires a five-step approach to determine the appropriate method of revenue recognition for each contractual arrangement: Step 1: Identify the Contract(s) with a Customer Step 2: Identify the Performance Obligation(s) in the Contract Step 3: Determine the Transaction Price Step 4: Allocate the Transaction Price to the Performance Obligation(s) in the Contract Step 5: Recognize Revenue when (or as) the Entity Satisfies a Performance Obligation The Company has entered into various license agreements for its owned trademarks. Under ASC 606, the Company’s agreements are generally considered symbolic licenses, which contain the characteristics of a right-to-access license since the customer is simultaneously receiving the intellectual property (“IP”) and benefiting from it throughout the license period. The Company assesses each license agreement at inception and determines the performance obligation(s) and appropriate revenue recognition method. As part of this process, the Company applies judgments based on historical trends when estimating future revenues and the period over which to recognize revenue. The Company generally recognizes revenue for license agreements under the following methods: 1. Licenses with guaranteed minimum royalties (“GMRs”) : Generally, guaranteed minimum royalty payments (fixed revenue) comprising the transaction price are recognized on a straight-line basis over the term of the contract, as defined in each license agreement. 2. Licenses with both GMRs (fixed revenue) and earned royalties (variable revenue) : Earned royalties in excess of fixed revenue are only recognized when the Company is reasonably certain that the guaranteed minimum payments for the period, as defined in each license agreement, will be exceeded. Additionally, the Company has categorized certain contracts as variable when there is a history and future expectation of exceeding GMRs. The Company recognizes income for these contracts during the period corresponding to the licensee’s sales. 3. Licenses that are sales-based only or earned royalties : Earned royalties (variable revenue) are recognized as income during the period corresponding to the licensee’s sales. Payments received as consideration for the grant of a license or advanced royalty payments are recorded as deferred revenue at the time payment is received and recognized into revenue under the methods described above. Contract assets represent unbilled receivables and are presented within accounts receivable, net on the condensed consolidated balance sheets. Contract liabilities represent unearned revenues and are presented within the current portion of deferred revenue on the condensed consolidated balance sheets. The Company disaggregates its revenue from continuing operations into two categories: licensing agreements and other, which is comprised of revenue from sources such as sales commissions and vendor placement commissions. Commission revenues and vendor placement commission revenues are recorded in the period the commission is earned. Restricted Cash Restricted cash consists of cash deposited with a financial institution required as collateral for the Company’s cash-collateralized letter of credit facilities. Accounts Receivable Accounts receivable are recorded net of allowances for doubtful accounts, based on the Company’s ongoing discussions with its licensees and other customers and its evaluation of their creditworthiness, payment history and account aging. Accounts receivable balances deemed to be uncollectible are written off after all means of collection have been exhausted and the potential for recovery is considered remote. The allowance for doubtful accounts was $1.9 million and $1.8 million as of September 30, 2019 and December 31, 2018, respectively. On June 10, 2019, the Company completed the sale of MSLO. As a result, accounts receivable, net, decreased $16.6 million which was recorded within current assets classified as held for disposition from discontinued operations as of December 31, 2018. The Company’s accounts receivable, net amounted to $41.4 million and $49.6 million as of September 30, 2019 and December 31, 2018, respectively. Two licensees accounted for approximately 49% (32% and 17%) of the Company’s total consolidated accounts receivable balance as of September 30, 2019 and two licensees accounted for approximately 41% (25%, and 16%) of the Company’s total consolidated accounts receivable balance as of December 31, 2018. The Company does not believe the accounts receivable balance from these licensees represents a significant collection risk based on past collection experience. Investments The Company accounts for equity securities under ASC 321, Investments – Equity Securities (“ASC 321”). Such securities are reported at fair value in the condensed consolidated balance sheets and, at the time of purchase, are reported in the condensed consolidated statements of cash flows as an investing activity. Gains and losses on equity securities are recognized through continuing operations. The Company recognized a loss on its equity securities of $0.4 million and $0.1 million recorded in other expense from continuing operations on the condensed consolidated statements of operations for the three and nine months ended September 30, 2019, respectively. No gain or loss was recorded in other income for the three and nine months ended September 30, 2018. Equity Method Investment For investments in entities over which the Company exercises significant influence but which do not meet the requirements for consolidation, the Company uses the equity method of accounting. On July 1, 2016, the Company acquired a 49.9% noncontrolling interest in Gaiam Pty. Ltd. in connection with its acquisition of Gaiam Brand Holdco, LLC, which is included in other assets in the condensed consolidated balance sheets. The Company’s share of earnings from its equity method investee, which was not material for the three and nine months ended September 30, 2019 and 2018, is included in other income from continuing operations in the unaudited condensed consolidated statements of operations. The Company evaluates its equity method investment for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investment may not be recoverable. The difference between the carrying value of the equity method investment and its estimated fair value is recognized as an impairment charge when the loss in value is deemed other-than-temporary. Intangible Assets On an annual basis (October 1 st ) and as needed, the Company tests indefinite lived trademarks for impairment through the use of discounted cash flow models. Assumptions used in the Company’s discounted cash flow models include: (i) discount rates; (ii) projected average revenue growth rates; and (iii) projected long-term growth rates. The Company’s estimates also factor in economic conditions and expectations of management, which may change in the future based on period-specific facts and circumstances. Other intangibles with determinable lives, including certain trademarks, customer agreements and patents, are evaluated for the possibility of impairment when certain indicators are present, and are otherwise amortized on a straight-line basis over the estimated useful lives of the assets (currently ranging from 2 to 15 years). On June 10, 2019, the Company completed the sale of MSLO. As a result, indefinite-lived intangible assets decreased by $330.1 million which was recorded within assets classified as held for disposition from discontinued operations as of December 31, 2018. During the first quarter of 2019, the Company recorded non-cash impairment charges of $161. 2 million for indefinite-lived intangible assets related to the Martha Stewart and Emeril Lagasse trademarks. The impairments arose as a result of the sale process for the Martha Stewart and Emeril Lagasse brands (as discussed in Note 3) due to the difference in the fair value as indicated by the sales price as compared to the carrying values of the intangible assets included in the transaction. The sale of the Martha Stewart and Emeril Lagasse brands was approved by the Board of Directors on April 15, 2019, to allow the Company to achieve one of its top priorities in significantly reducing its debt. Going forward the Company’s strategy is to focus on higher margin brands that are well suited for growing health, wellness and beauty categories. These charges are included in discontinued operations in the unaudited condensed consolidated statements of operations. See Note 3 and Note 7. During the three months ended September 30, 2019, the Company recorded non-cash impairment charges of $33.1 million consisting of $28.5 million related to the Jessica Simpson trademark and $4.6 million related to the Joe’s trademark. During the three months ended September 30, 2018, the Company recorded non-cash impairment charges of $17.9 million for indefinite-lived intangible assets related to two of the Company’s non-core brands: Ellen Tracy and Caribbean Joe . The impairments arose due to reduced growth expectations and the impact of licensee transitions for these brands. Fair value for each trademark was determined based on the income approach using estimates of future discounted cash flows. These charges are included in impairment charges in the unaudited condensed consolidated statements of operations. See Note 4 and Note 7. Treasury Stock Treasury stock is recorded at cost as a reduction of equity in the condensed consolidated balance sheets. Stock-Based Compensation Compensation cost for restricted stock is measured using the quoted market price of the Company’s common stock at the date the common stock is granted. For restricted stock and restricted stock units, for which restrictions lapse with the passage of time (“time-based restricted stock”), compensation cost is recognized on a straight-line basis over the period between the issue date and the date that restrictions lapse. Time-based restricted stock is included in total shares of common stock outstanding upon the lapse of applicable restrictions. For restricted stock, for which restrictions are based on performance measures (“performance stock units” or “PSUs”), restrictions lapse when those performance measures have been deemed achieved. Compensation cost for PSUs is recognized on a straight-line basis during the period from the date on which the likelihood of the PSUs being earned is deemed probable and (x) the end of the fiscal year during which such PSUs are expected to vest or (y) the date on which awards of such PSUs may be approved by the compensation committee of the Company’s board of directors (the “Compensation Committee”) on a discretionary basis, as applicable. PSUs are included in total shares of common stock outstanding upon the lapse of applicable restrictions. PSUs are included in total diluted shares of common stock outstanding when the performance measures have been deemed achieved but the PSUs have not yet been issued. Fair value for stock options and warrants is calculated using the Black-Scholes valuation model and is expensed on a straight-line basis over the requisite service period of the grant. Compensation cost is reduced for forfeitures as they occur in accordance with Accounting Standards Update (“ASU”) 2016‑09, Simplifying the Accounting for Share-Based Payments (“ASU 2016‑09”) . The Company adopted ASU No. 2018-07, Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”) as of January 1, 2019 on a modified retrospective basis. In accordance with ASU 2018-07, the Company recognizes compensation cost for grants to non-employees on a straight-line basis over the period of the grant. Prior periods have not been restated and were accounted for under the previous method where at each reporting period prior to the lapse of restrictions on warrants, time-based restricted stock and PSUs granted to non-employees, the Company remeasured the aggregate compensation cost of such grants using the Company’s fair value at the end of such reporting period and revised the straight-line recognition of compensation cost in line with such remeasured amount. Leases The Company has operating leases for certain properties for its offices and showrooms and for copiers. The Company adopted ASU No. 2016-02, Leases (“ASU 2016-02” or “ASC 842”) as of January 1, 2019 using the modified retrospective method as of the period of adoption. The Company elected the package of practical expedients upon transition where the Company did not reassess the lease classification and initial direct costs for leases that existed prior to adoption. Additionally, the Company did not reassess contracts entered into prior to adoption to determine whether the arrangement was or contained a lease. In accordance with ASU 2016-02, for leases over twelve months the Company records a right-of-use asset and a lease liability representing the present value of future lease payments. Rent expense is recognized on a straight-line basis over the term of the lease. See Note 6 for further information. Income Taxes Current income taxes are based on the respective periods’ taxable income for federal, foreign and state income tax reporting purposes. Deferred tax liabilities and assets are determined based on the difference between the financial statement and income tax bases of assets and liabilities, using statutory tax rates in effect for the year in which the differences are expected to reverse. In accordance with ASU No. 2015‑17, Balance Sheet Classification of Deferred Taxes , all deferred income taxes are reported and classified as non-current. A valuation allowance is required if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company applies the Financial Accounting Standards Board (“FASB”) guidance on accounting for uncertainty in income taxes. The guidance clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements in accordance with other authoritative GAAP and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The guidance also addresses derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. During the nine months ended September 30, 2019 and year ended December 31, 2018, the Company did not have any reserves or interest and penalties to record through current income tax expense in accordance with ASC 740, Income Taxes (“ASC 740”). Interest and penalties related to uncertain tax positions, if any, are recorded in income tax expense. Tax years that remain open for assessment for federal and state tax purposes include the years ended December 31, 2015 through December 31, 2018. Earnings Per Share Basic loss per share (“EPS”) attributable to Sequential Brands Group, Inc. and Subsidiaries is computed by dividing net loss attributable to Sequential Brands Group, Inc. and Subsidiaries by the weighted-average number of common shares outstanding during the reporting period, excluding the effects of any potentially dilutive securities. Diluted EPS gives effect to all potentially dilutive common shares outstanding during the reporting period, including stock options, PSUs and warrants, using the treasury stock method, and convertible debt, using the if-converted method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive. B asic weighted-average common shares outstanding is equivalent to diluted weighted-average common shares outstanding for the three and nine months ended September 30, 2019 and 2018. Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 Basic weighted-average common shares outstanding 64,952,093 63,911,481 64,622,332 63,578,121 Performance based restricted stock — — — — Unvested restricted stock — — — — Diluted weighted-average common shares outstanding 64,952,093 63,911,481 64,622,332 63,578,121 The computation of diluted EPS for the three and nine months ended September 30, 2019 and 2018 excludes the following potentially dilutive securities because their inclusion would be anti-dilutive: Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 Unvested restricted stock 38,585 328,353 506,035 995,568 Performance based restricted stock — 31,162 — 49,202 Total 38,585 359,515 506,035 1,044,770 The weighted-average common shares outstanding used to calculate diluted EPS from discontinued operations for the three and nine months ended September 30, 2018 is 64,270,995 and 64,622,891, respectively. Concentration of Credit Risk Financial instruments which potentially expose the Company to credit risk consist primarily of cash, restricted cash and accounts receivable. Cash is held to meet working capital needs and future acquisitions. Restricted cash is pledged as collateral for a comparable amount of irrevocable standby letters of credit for certain of the Company’s leased properties. Substantially all of the Company’s cash and restricted cash are deposited with high quality financial institutions. At times, however, such cash and restricted cash may be in deposit accounts that exceed the Federal Deposit Insurance Corporation insurance limit. The Company has not experienced any losses in such accounts as of September 30, 2019. Concentration of credit risk with respect to accounts receivable is minimal due to the collection history. The Company performs periodic credit evaluations of its customers’ financial condition. The allowance for doubtful accounts is based upon the expected collectability of all accounts receivable. Customer Concentrations The Company recorded net revenues from continuing operations of $25.4 million and $29.5 million during the three months ended September 30, 2019 and 2018, respectively. During the three months ended September 30, 2019, three licensees represented at least 10% of net revenue from continuing operations, accounting for 17%, 17% and 16% of the Company’s net revenue from continuing operations. During the three months ended September 30, 2018, three licensees represented at least 10% of net revenue from continuing operations, accounting for 21%, 14% and 11% of the Company’s net revenue from continuing operations. The Company recorded net revenues from continuing operations of $77.3 million and $92.0 million during the nine months ended September 30, 2019 and 2018, respectively. During the nine months ended September 30, 2019, three licensees represented at least 10% of net revenue from continuing operations, accounting for 19%, 16% and 14% of the Company’s net revenue from continuing operations. During the nine months ended September 30, 2018, two licensees represented at least 10% of net revenue from continuing operations, accounting for 18% and 13% of the Company’s net revenue from continuing operations. Loss Contingencies The Company recognizes contingent losses that are both probable and estimable. In this context, probable means circumstances under which events are likely to occur. The Company records legal costs pertaining to contingencies as incurred. Noncontrolling Interest Noncontrolling interest recorded for the three and nine months ended September 30, 2019 in continuing operations represents income allocations to Elan Polo International, Inc., a member of DVS Footwear International, LLC and With You, Inc., a member of With You LLC (the partnership between the Company and Jessica Simpson). Discontinued Operations The Company accounted for the sale of MSLO in accordance with ASC 360, Accounting for Impairment or Disposal of Long-Lived Assets (“ASC 360”) and Accounting Standard Update No. 2014-08, Reporting of Discontinued Operations and Disclosures of Disposals of Components of an Entity (“ASU 2014-08”). The Company followed the held-for-sale criteria as defined in ASC 360. ASC 360 requires that a component of an entity that has been disposed of or is classified as held for sale and has operations and cash flows that can be clearly distinguished from the rest of the entity be reported as assets held for sale and discontinued operations. In the period a component of an entity has been disposed of or classified as held for sale, the results of operations for the periods presented are reclassified into separate line items in the statements of operations. Assets and liabilities are also reclassified into separate line items on the related balance sheets for the periods presented. The statements of cash flows for the periods presented are also reclassified to reflect the results of discontinued operations as separate line items. ASU 2014-08 requires that only a disposal of a component of an entity, or a group of components of an entity, that represents a strategic shift that has, or will have, a major effect on the reporting entity’s operations and financial results be reported in the financial statements as discontinued operations. ASU 2014-08 also provides guidance on the financial statement presentations and disclosures of discontinued operations. Reportable Segment An operating segment, in part, is a component of an enterprise whose operating results are regularly reviewed by the chief operating decision maker (the “CODM”) to make decisions about resources to be allocated to the segment and assess its performance. Operating segments may be aggregated only to a limited extent. The Company’s CODM, the President, reviews financial information presented on a consolidated basis, accompanied by disaggregated information about revenues for purposes of making operating decisions and assessing financial performance. Accordingly, the Company has determined that it has a single operating and reportable segment. In addition, the Company has no foreign offices or any assets in foreign locations. The majority of the Company’s operations consist of a single revenue stream, which is the licensing of its trademark portfolio, with additional revenues derived from television, book, and certain commissions. New Accounting Pronouncements ASU No. 2018-18, “Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606” In November 2018, the FASB issued ASU No. 2018-18 “ Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606 ” (“ASU 2018-18”). ASU 2018-18 amends ASC 808, Collaborative Arrangements (“ ASC 808”) and ASC 606, Revenue from Contracts with Customers (“ASC 606”) to clarify that certain transactions between participants in a collaborative arrangement should be accounted for under ASC 606 when the counterparty is a customer. ASU 2018-18 is effective for annual and interim periods beginning after December 15, 2019, and early adoption is permitted. The Company does not expect the adoption of ASU 2018-18 to have a material impact on the Company’s consolidated financial statements. ASU No. 2018-15, “ Intangibles—Goodwill and Other— Internal-Use Software (Subtopic 350-40) Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract” In August 2018, the FASB issued ASU No. 2018-15, “ Intangibles—Goodwill and Other— Internal-Use Software (Subtopic 350-40) Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract” (“ASU 2018-15”). Under ASU 2018-15 customers will apply the same criteria used for capitalizing implementation costs incurred for an internal-use software license to implementation costs incurred in a cloud computing arrangement. ASU 2018-15 is effective for annual and interim periods beginning after December 15, 2019, and early adoption is permitted. The Company does not expect the adoption of ASU 2018-15 to have a material impact on the Company condensed consolidated financial statements. ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement” In August 2018, the FASB issued ASU No. 2018-13 “ Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement ” (“ASU 2018-13”). ASU 2018-13 eliminates, amends, and adds certain disclosure requirements for fair value measurements. ASU 2018-13 is effective for annual and interim periods beginning after December 15, 2019, and early adoption is permitted for the entire standard or for the provisions that eliminate or amend disclosure requirements. The Company does not expect the adoption of ASU 2018-13 to have a material impact on the Company’s condensed consolidated financial statements.

Discontinued Operations

Discontinued Operations	9 Months Ended
	Sep. 30, 2019
Discontinued Operations
Discontinued Operations	3. Discontinued Operations On June 10, 2019, the Company completed the sale of MSLO, a Delaware corporation and a wholly-owned subsidiary of the Company, for $166 million in cash consideration, plus additional amounts in respect of pre-closing accounts receivable that are received after the closing, subject to certain adjustments, pursuant to the Purchase Agreement with the Buyer entered into on April 16, 2019. In addition, the Purchase Agreement provides for an earnout of up to $40,000,000 if certain performance targets are achieved during the three calendar years ending December 31, 2020, December 31, 2021 and December 31, 2022. MSLO and its subsidiaries were engaged in the business of promoting, marketing and licensing the Martha Stewart and the Emeril Lagasse brands through various distribution channels. The Company recorded a pre-tax loss of $2.0 million on the sale of MSLO during the nine months ended September 30, 2019 which is recorded in discontinued operations in the unaudited condensed consolidated statements of operations. During the first quarter of 2019, the Company recorded non-cash impairment charges of $161. 2 million for indefinite-lived intangible assets related to the Martha Stewart and Emeril Lagasse trademarks. The impairments arose during the sale process for the Martha Stewart and Emeril Lagasse brands due to the difference in the fair value as indicated by the sales price as compared to the carrying values of the intangible assets included in the transaction. The sale of the Martha Stewart and Emeril Lagasse brands was approved by the Board of Directors on April 15, 2019, to allow the Company to achieve one of its top priorities in significantly reducing its debt. Going forward the Company’s strategy is to focus on higher margin brands that are well suited for growing health, wellness and beauty categories. These charges are included in discontinued operations in the unaudited condensed consolidated statements of operations. The Company recorded a net loss from discontinued operations of $0.3 million and $122.2 million for the three and nine months ended September 30, 2019, respectively. The financial results of MSLO through September 30, 2019 are presented as (loss) income from discontinued operations, net of taxes in the unaudited condensed consolidated statements of operations. The following table presents the discontinued operations in the unaudited condensed consolidated statements of operations: Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 (in thousands) Net revenue $ - $ 11,315 $ 18,771 $ 29,037 Operating expenses 114 8,100 16,503 18,033 Impairment charges - - 161,224 - Loss on sale of MSLO - - 2,008 - (Loss) income from operations (114) 3,215 (160,964) 11,004 Other expense 136 - 236 - Interest expense - 1,773 3,570 5,066 (Loss) income from discontinued operations before income taxes (250) 1,442 (164,770) 5,938 Provision for (benefit from) income taxes 59 595 (42,578) 2,451 (Loss) income from discontinued operations $ (309) $ 847 $ (122,192) $ 3,487 The Company used cash proceeds from the MSLO sale to make mandatory prepayments of $109.6 million on the Revolving Credit Facility and voluntary prepayments of $44.4 million on its Tranche A-1 Term Loans (see Note 8) . In accordance with ASC 205-20-45-6, Presentation of Financial Statements – Discontinued Operations , the Company has allocated interest expense of $1.8 million for the three months ended September 30, 2018 related to the portion of debt that was required to be paid as part of the transaction and accretion on MS Legacy (as defined in Note 4) and guaranteed payments. No interest expense was allocated for the three months ended September 30, 2019. The Company allocated interest expense of $3.6 million and $5.1 million for the nine months ended September 30, 2019 and 2018, respectively, related to the portion of debt that was required to be paid as part of the transaction and accretion on MS Legacy and guaranteed payments. During the three and nine months ended September 30, 2019, the Company recorded less than $0.1 million and $6.0 million, respectively, in transaction costs directly related to the sale of MSLO which are recorded in discontinued operations in the unaudited condensed consolidated statements of operations. The following table presents the assets and liabilities classified as held for sale from discontinued operations as of September 30, 2019 and December 31, 2018: September 30, December 31, 2019 2018 (in thousands) Carrying amount of assets included as part of discontinued operations: Current Assets: Accounts receivable, net $ - $ 16,602 Prepaid expenses and other current assets 9,218 7,243 Total current assets classified as held for disposition from discontinued operations 9,218 23,845 Property and equipment, net - 580 Intangible assets, net - 330,084 Total assets classified as held for disposition from discontinued operations $ 9,218 $ 354,509 Carrying amount of liabilities included as part of discontinued operations: Current Liabilities: Accounts payable and accrued expenses $ 3,731 $ 11,927 Current portion of deferred revenue - 3,523 Total current liabilities classified as held for disposition from discontinued operations 3,731 15,450 Deferred income taxes - 34,938 Other long-term liabilities - 3,629 Total liabilities classified as held for disposition from discontinued operations $ 3,731 $ 54,017 The prepaid expenses and other current assets at September 30, 2019 consists of a $9.2 million receivable due to the Company from the Buyer in accordance with the terms of the Purchase Agreement. The following table presents the cash flow from discontinued operations for the nine months ended September 30, 2019 and 2018: Nine Months Ended September 30, 2019 2018 (in thousands) Cash provided by discontinued operating activities $ 7,647 $ 4,711 Cash used in discontinued investing activities $ (44) $ (44) Cash used in discontinued financing activities $ (574) $ (975)

Fair Value Measurement of Finan

Fair Value Measurement of Financial Instruments	9 Months Ended
	Sep. 30, 2019
Fair Value Measurement of Financial Instruments [Abstract]
Fair Value Measurement of Financial Instruments	4. Fair Value Measurement of Financial Instruments ASC 820‑10, Fair Value Measurements and Disclosures (“ASC 820‑10”), defines fair value, establishes a framework for measuring fair value in GAAP and provides for expanded disclosure about fair value measurements. ASC 820‑10 applies to all other accounting pronouncements that require or permit fair value measurements. The Company determines or calculates the fair value of financial instruments using quoted market prices in active markets when such information is available or using appropriate present value or other valuation techniques, such as discounted cash flow analyses, incorporating available market discount rate information for similar types of instruments while estimating for non-performance and liquidity risk. These techniques are significantly affected by the assumptions used, including the discount rate, credit spreads and estimates of future cash flows. Assets and liabilities typically recorded at fair value on a non-recurring basis to which ASC 820‑10 applies include: · non-financial assets and liabilities initially measured at fair value in an acquisition or business combination, and · long-lived assets measured at fair value due to an impairment assessment under ASC 360‑10‑15, Impairment or Disposal of Long-Lived Assets . This topic defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and establishes a three-level hierarchy, which encourages an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820‑10 requires that assets and liabilities recorded at fair value be classified and disclosed in one of the following three categories: · Level 1 - inputs utilize quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access. · Level 2 - inputs utilize other-than-quoted prices that are observable, either directly or indirectly. Level 2 inputs include quoted prices for similar assets and liabilities in active markets, and inputs such as interest rates and yield curves that are observable at commonly quoted intervals. · Level 3 - inputs are unobservable and are typically based on the Company’s own assumptions, including situations where there is little, if any, market activity. Both observable and unobservable inputs may be used to determine the fair value of positions that are classified within the Level 3 classification. In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the Company classifies such financial assets or liabilities based on the lowest level input that is significant to the fair value measurement in its entirety. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the asset or liability. On June 10, 2019, the Company completed the sale of MSLO. As a result, indefinite-lived intangible assets decreased by $330.1 million which was recorded within assets classified as held for disposition from discontinued operations as of December 31, 2018. During the first quarter of 2019, the Company had recorded non-cash impairment charges of $161.2 million for these indefinite-lived intangible assets related to the Martha Stewart and Emeril Lagasse trademarks. The impairments arose during the sale process for the Martha Stewart and Emeril Lagasse brands (as discussed in Notes 3 and 7) due to the difference in the fair value as indicated by the sales price as compared to the carrying values of the intangible assets included in the transaction. The sale of the Martha Stewart and Emeril Lagasse brands was approved by the Board of Directors during the second quarter of 2019, to allow the Company to achieve one of its top priorities in significantly reducing its debt. Going forward the Company’s strategy is to focus on higher margin brands that are well suited for growing health, wellness and beauty categories. During the three months ended September 30, 2019, the Company recorded non-cash impairment charges of $33.1 million consisting of $28.5 million related to the Jessica Simpson trademark and $4.6 million related to the Joe’s trademark. During the three months ended September 30, 2018, the Company recorded non-cash impairment charges of $17.9 million for indefinite-lived intangible assets related to the trademarks of two of the Company’s non-core brands: Ellen Tracy and Caribbean Joe . The impairments arose due to reduced growth expectations and the impact of licensee transitions for these brands. Fair value for each trademark was determined based on the income approach using estimates of future discounted cash flows, a Level 3 measurement within the fair value hierarchy. As of September 30, 2019 and December 31, 2018, there were no assets or liabilities that are required to be measured at fair value on a recurring basis, except for interest rate swaps and equity securities. The following table sets forth the carrying value and the fair value of the Company’s financial assets and liabilities required to be disclosed at September 30, 2019 and December 31, 2018: Carrying Value Fair Value Financial Instrument Level 9/30/2019 12/31/2018 9/30/2019 12/31/2018 (in thousands) Equity securities 1 $ 542 $ 627 $ 542 $ 627 Interest rate swaps - liability 2 $ 7,474 $ 2,019 $ 7,474 $ 2,019 Term loans 2 $ 456,331 $ 519,850 $ 453,497 $ 515,742 Revolving loan 2 $ 5,358 $ 115,000 $ 5,357 $ 114,827 The carrying amounts of the Company’s cash, restricted cash, accounts receivable and accounts payable approximate fair value due to their short-term maturities. In December 2018, the Company entered into interest rate swap agreements related to its term loans (the “2018 Swap Agreements”) with certain financial institutions. The Company recorded its interest rates swaps in accounts payable and accrued expenses and other long-term liabilities on the condensed consolidated balance sheets at fair value using Level 2 inputs. The 2018 Swap Agreements have a $300 million notional value and $150 million matures on December 31, 2021 and $150 million matures on January 4, 2022. The Company’s risk management objective and strategy with respect to the 2018 Swap Agreements is to reduce its exposure to variability in cash flows on a portion of the Company’s floating-rate debt. The 2018 Swap Agreements protect the Company from increases in changes in its cash flows attributable to changes in a contractually specified interest rate on an amount of borrowing equal to the then outstanding swap notional. The Company periodically assesses the effectiveness of the hedges (both prospective and retrospective) by performing a single regression analysis that was prepared at the inception of the hedging relationship. To the extent a hedging relationship is highly effective, the gain or loss on the swap will be recorded in accumulated other comprehensive loss and reclassified into interest expense in the same period during which the hedged transactions affect earnings. During the nine months ended September 30, 2019, the Company determined that a portion of one of the hedges was no longer effective due to the repayment of certain debt with the proceeds from the sale of MSLO (see Note 8). As a result, in accordance with ASC 815-30-40-6A, the Company de-designated it as a cash flow hedge and reclassified a loss of $0.4 million from other comprehensive loss to other expense in the unaudited condensed consolidated statement of operations. Changes in the fair value of the de-designated interest rate swap after the de-designation date are being recognized through continuing operations. The Company recorded a loss of $0.4 million and $0.9 million in other expense from continuing operations in the unaudited condensed consolidated statements of operations for the three and nine months ended September 30, 2019, respectively. The components of the 2018 Swap Agreements as of September 30, 2019 are as follows: Notional Value Derivative Asset Derivative Liability (in thousands) LIBOR based loans $ 300,000 $ — $ 7,474 For purposes of this fair value disclosure, the Company based its fair value estimate for the Term Loans and Revolving Loan (each, as defined in Note 8 – both under and prior to the amendment) on its internal valuation whereby the Company applied the discounted cash flow method to its expected cash flow payments due under the loan agreements based on interest rates as of September 30, 2019 and December 31, 2018 for debt with similar risk characteristics and maturities. On June 10, 2019, the Company completed the sale of MSLO. As a result, Legacy Payments (as defined below) decreased by $2.6 million which was recorded in long-term liabilities held for disposition from discontinued operations as of December 31, 2018 as we are no longer party to the obligation. In connection with the previous acquisition of MSLO, beginning with calendar years commencing on or after January 1, 2026, the Company would have paid Ms. Stewart three and one-half percent (3.5%) of Gross Licensing Revenues (as defined in Ms. Stewart’s employment agreement) for each such calendar year for the remainder of Ms. Stewart’s life (with a minimum of five (5) years of payments, to be made to Ms. Stewart’s estate if Ms. Stewart died before December 31, 2030) (the “Legacy Payments”).

Revenues

Revenues	9 Months Ended
	Sep. 30, 2019
Revenues [Abstract]
Revenue	5. Revenues The Company has entered into various license agreements that provide revenues in exchange for use of the Company’s IP. Licensing agreements are the Company’s primary source of revenue. The Company also derives revenue from other sources such as sales commissions and vendor placement commissions. Disaggregated Revenue The following table presents revenue from continuing operations disaggregated by source: Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 (in thousands) Licensing agreements $ 25,084 $ 26,836 $ 76,859 $ 85,413 Other 308 2,619 472 6,631 Total $ 25,392 $ 29,455 $ 77,331 $ 92,044 Contract Balances Contract assets represent unbilled receivables and are presented within accounts receivable, net on the condensed consolidated balance sheets. Contract liabilities represent unearned revenues and are presented within the current portion of deferred revenue on the condensed consolidated balance sheets. The below table summarizes the Company’s contract assets and contract liabilities: September 30, December 31, 2019 2018 (in thousands) Contract assets $ 2,177 $ 2,484 Contract liabilities 3,403 4,923 On June 10, 2019, the Company completed the sale of MSLO, as a result contract assets and liabilities decreased $0.7 million and $0.1 million, respectively, and are recorded in current assets and liabilities held for disposition from discontinued operations as of December 31, 2018. Performance Obligations A performance obligation is a promise in a contract to transfer a distinct good or service to the customer. The Company has reviewed its various revenue streams for its existing contracts under the five-step approach. The Company has entered into various license agreements that provide revenues based on guaranteed minimum royalty payments with additional royalty revenues based on a percentage of defined sales. Guaranteed minimum royalty payments (fixed revenue) are recognized on a straight-line basis over the term of the contract, as defined in each license agreement. Earned royalties and earned royalties in excess of the fixed revenue (variable revenue) are recognized as income during the period corresponding to the licensee’s sales. Earned royalties in excess of fixed revenue are only recognized when the Company is reasonably certain that the guaranteed minimums payments for the period, as defined in each license agreement, will be exceeded. Licensing for trademarks is the Company’s largest revenue source. Under ASC 606, the Company’s agreements are generally considered symbolic licenses which contain the characteristics of a right-to-access license since the customer is simultaneously receiving the IP and benefiting from it throughout the license period. As such, the Company primarily records revenue from licenses on a straight-line basis over the license period as the performance obligation is satisfied over time. The Company applies its judgment based on historical trends when estimating future revenues and the period over which to recognize revenue when evaluating its licensing contracts. Deferred revenue will be recognized as the Company fulfills its performance obligations over periods of approximately one to five years. The below table summarizes amounts related to future performance obligations from continuing operations under fixed contractual arrangements as of September 30, 2019 and the periods in which they are expected to be earned and recognized as revenue: 2019 2020 2021 2022 2023 Thereafter (in thousands) Future Performance Obligations $ 14,514 $ 40,576 $ 26,107 $ 5,929 $ 4,555 $ 244 The Company does not disclose the amount attributable to unsatisfied or partially satisfied performance obligations for variable revenue contracts in accordance with the optional exemption allowed for under ASC 606. The Company has categorized certain contracts as variable when there is a history and future expectation of exceeding guaranteed minimum royalties.

Leases

Leases	9 Months Ended
	Sep. 30, 2019
Lease
Leases	6. Leases The Company has operating leases for certain properties for its offices and showrooms and for copiers. The Company adopted ASU 2016-02 as of January 1, 2019 using the modified retrospective method as of the period of adoption. The Company elected the package of practical expedients upon transition where the Company did not reassess the lease classification and initial direct costs for leases that existed prior to adoption. Additionally, the Company did not reassess contracts entered into prior to adoption to determine whether the arrangement was or contained a lease. At January 1, 2019, the Company did not have any leases that had not yet commenced. The Company also elected the practical expedient to not recognize right-of-use assets or lease liabilities for leases with a term of twelve months or less. The Company determines if an arrangement contains a lease and the lease term at contract inception based on the terms of each arrangement. The Company’s operating leases contain options to extend and early termination options. The Company will evaluate the terms on a lease-by-lease basis and include options to extend or early termination options when it is reasonably certain that the Company will exercise the option. For arrangements that are identified as leases and are over twelve months the Company records a right-of-use (“ROU”) asset and a lease liability representing the present value of future lease payments. Under ASC 842, the present value of future lease payments must be discounted by using the interest rate implicit in the lease, or if not readily determinable, its incremental borrowing rate. The Company used an average cost of debt of 6.76% as the discount rate for the leases as it is representative of the interest rate that would be charged to borrow an amount equal to the lease payments on a fully collateralized basis. The operating lease assets and liabilities recorded on the condensed consolidated balance sheet as of September 30, 2019 are summarized as follows: September 30, Classification on Balance Sheet 2019 Assets (in thousands) Non-current Right-of-use assets - operating leases $ 48,237 Liabilities Current Current portion of lease liabilities - operating leases $ 2,869 Non-current Lease liabilities - operating leases 52,285 Total operating lease liabilities $ 55,154 Weighted average remaining lease term (in years) 13.6 Rent expense is recognized on a straight-line basis over the term of the lease. Rent expense for operating leases was $1.5 million for each of the three months ended September 30, 2019 and 2018. Rent expense for operating leases was $4.6 million and $4.5 million for the nine months ended September 30, 2019 and 2018, respectively. Sublease income was $0.4 million and $0.1 million for the three months ended September 30, 2019 and 2018, respectively. Sublease income was $0.8 million and $0.5 million for the nine months ended September 30, 2019 and 2018, respectively. All of the aforementioned amounts are included in continuing operations. As of September 30, 2019, the maturities of the Company’s lease liabilities were as follows: Operating Leases (in thousands) 2019 (remaining three months) $ 1,632 2020 6,450 2021 6,295 2022 6,295 2023 6,277 Thereafter 58,320 Total minimum lease payments 85,269 Less: imputed interest 30,115 Lease liabilities $ 55,154

Intangible Assets

Intangible Assets	9 Months Ended
	Sep. 30, 2019
Intangible Assets [Abstract]
Intangible Assets	7. Intangible Assets Intangible assets are summarized as follows: Gross Useful Lives Carrying Accumulated Net Carrying September 30, 2019 (Years) Amount Amortization Amount (in thousands) Finite-lived intangible assets: Trademarks 5 - 15 $ 12,480 $ (4,056) $ 8,424 Customer agreements 4 2,200 (2,196) 4 Patents 10 95 (62) 33 $ 14,775 $ (6,314) 8,461 Indefinite-lived intangible assets: Trademarks 591,933 Intangible assets, net $ 600,394 Gross Useful Lives Carrying Accumulated Net Carrying December 31, 2018 (Years) Amount Amortization Amount (in thousands) Finite-lived intangible assets: Trademarks 5 - 15 $ 12,438 $ (2,689) $ 9,749 Customer agreements 4 2,200 (2,147) 53 Patents 10 361 (321) 40 $ 14,999 $ (5,157) 9,842 Indefinite-lived intangible assets: Trademarks 624,985 Intangible assets, net $ 634,827 Estimated future annual amortization expense for intangible assets in service as of September 30, 2019 is summarized as follows: Years Ended December 31, (in thousands) Remainder of 2019 $ 462 2020 1,838 2021 1,835 2022 1,812 2023 1,387 Thereafter 1,127 $ 8,461 Amortization expense from continuing operations was approximately $0.5 million and $0.2 million for the three months ended September 30, 2019 and 2018, respectively. Amortization expense from continuing operations was approximately $1.4 million and $0.5 million for the nine months ended September 30, 2019 and 2018, respectively. Finite-lived intangible assets represent trademarks, customer agreements and patents related to the Company’s brands. Finite-lived intangible assets are amortized on a straight-line basis over the estimated useful lives of the assets. The carrying value of finite-lived intangible assets and other long-lived assets is reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Indefinite-lived intangible assets are not amortized, but instead are subject to impairment evaluation. As of September 30, 2019, the trademarks of Jessica Simpson, Avia, AND1, Joe’s, GAIAM, Caribbean Joe, and Ellen Tracy have been determined to have indefinite useful lives, and accordingly, consistent with ASC Topic 350, no amortization has been recorded in the Company’s unaudited condensed consolidated statements of operations. Instead, each of these intangible assets are tested for impairment annually and as needed on an individual basis as separate single units of accounting, with any related impairment charge recorded to the statement of operations at the time of determining such impairment. The annual evaluation of the Company’s indefinite-lived trademarks is performed as of October 1, the beginning of the Company’s fourth fiscal quarter. In June 2019, the Company completed the sale of MSLO. As a result, indefinite-lived intangible assets decreased by $330.1 million which was recorded within assets classified as held for disposition from discontinued operations as of December 31, 2018. During the first quarter of 2019, the Company recorded non-cash impairment charges of $161.2 million for indefinite-lived intangible assets related to the Martha Stewart and Emeril Lagasse trademarks reflected in discontinued operations on the unaudited condensed consolidated statements of operations. The impairments arose during the sale process for the Martha Stewart and Emeril Lagasse brands (as discussed in Note 3) due to the difference in the fair value as indicated by the sales price as compared to the carrying values of the intangible assets included in the transaction. The sale of the Martha Stewart and Emeril Lagasse brands was approved by the Board of Directors during the second quarter of 2019, to allow the Company to achieve one of its top priorities in significantly reducing its debt. Going forward the Company’s strategy is to focus on higher margin brands that are well suited for growing health, wellness and beauty categories. During the three months ended September 30, 2019, the Company recorded non-cash impairment charges of $33.1 million consisting of $28.5 million related to the Jessica Simpson trademark and $4.6 million related to the Joe’s trademark. During the three months ended September 30, 2018, the Company recorded non-cash impairment charges of $17.9 million for indefinite-lived intangible assets related to the trademarks of two of the Company’s non-core brands: Ellen Tracy and Caribbean Joe . The impairments arose due to reduced growth expectations and the impact of licensee transitions for these brands. Fair value for each trademark was determined based on the income approach using estimates of future discounted cash flows. These charges are included in impairment charges in the unaudited condensed consolidated statements of operations. During the nine months ended September 30, 2018, the Company sold both the Revo and FUL trademarks. During the nine months ended September 30, 2018, the Company incurred a loss on the sale of the assets of $7.1 million.

Long-Term Debt

Long-Term Debt	9 Months Ended
	Sep. 30, 2019
Long-Term Debt [Abstract]
Long-Term Debt	8. Long-Term Debt The components of long-term debt are as follows: September 30, December 31, 2019 2018 (in thousands) Secured Term Loans $ 456,331 $ 519,850 Revolving Credit Facility 5,358 115,000 Unamortized deferred financing costs (22,608) (24,063) Total long-term debt, net of unamortized deferred financing costs 439,081 610,787 Less: current portion of long-term debt 21,000 28,300 Long-term debt $ 418,081 $ 582,487 August 2018 Debt Facilities On August 12, 2019, the Company amended its Third Amended and Restated First Lien Credit Agreement (the “Amended FS/KKR Credit Agreement”) with Wilmington Trust, National Association, as administrative agent and collateral agent (the “FS/KKR Agent”) and the lenders party thereto (the “FS/KKR Facility Loan Parties”). Pursuant to the Amended KKR/FS Credit Agreement, no mandatory amortization payments are required until September 30, 2020. Thereafter, the loans under the Amended KKR/FS Credit Agreement will be subject to quarterly amortization payments of $1.0 million. Pursuant to the Amended KKR/FS Credit Agreement, no payment with proceeds of any consolidated excess cash flow will be required to be made prior to the fiscal year ending December 31, 2020. The Amended KKR/FS Credit Agreement modified the calculation of Consolidated EBITDA (as defined in the agreement) by permitting additional addbacks and specifying the EBITDA amounts for the quarters ended September 30, 2018, December 31, 2018, March 31, 2019 and June 30, 2019. The Amended KKR/FS Credit Agreement allows for the netting of up to $5 million in cash of the Company and its subsidiaries for purposes of calculating the leverage ratio covenant. The Company also agreed under the Amended KKR/FS Credit Agreement not to borrow more than $30 million under the Bank of America Revolving Credit Facility. During the three months ended September 30, 2019, the Company incurred $3.3 million in lender fees associated with the amendment which was recorded in deferred financing costs in accordance with ASC 470, Debt and included in long-term debt, net of current portion in the condensed consolidated balance sheet. These fees are being amortized using the effective interest rate method over the remainder of the term of the Amended KKR/FS Credit Agreement. On June 10, 2019, the Company completed the sale of MSLO. The Company used cash proceeds from the MSLO sale to make mandatory prepayments of $109.6 million of the Revolving Credit Facility and voluntary prepayments of $44.4 million on its Tranche A-1 Term Loans . The Company expensed $0.6 million of deferred financing costs during the nine months ended September 30, 2019, included in interest expense in the unaudited condensed consolidated statements of operations as a result of the partial paydown on the Tranche A-1 Term Loan. On August 7, 2018 (the “Closing Date”), the Company and certain of its subsidiaries amended its (i) Third Amended and Restated First Lien Credit Agreement (the “Amended BoA Credit Agreement”) with Bank of America, N.A., as administrative agent and collateral agent and the lenders party thereto (the “BoA Facility Loan Parties”) and (ii) Amended FS/KKR Credit Agreement with the FS/KKR Agent and the FS/KKR Facility Loan Parties. The Company used a portion of the proceeds of the $335.0 million loans made to the Company under the Amended BoA Credit Agreement to prepay loans under the Amended FS/KKR Credit Agreement. The Amended BoA Credit Agreement provides for several five-year senior secured credit facilities, consisting of (i) Tranche A Term Loans in an aggregate principal amount of $150.0 million (the “Amended Tranche A Loans”), (ii) Tranche A‑1 Term Loans in an aggregate principal amount of $70.0 million (the “Amended Tranche A‑1 Loans” and, together with the Tranche A Loans, the “Amended BoA Term Loans”) and (iii) revolving credit commitments in the aggregate principal amount of $130.0 million (the “Amended Revolving Credit Commitments” and, the loans under the Revolving Credit Commitments, the “Amended Revolving Loans”). On the Closing Date, the total amount outstanding under the Amended BoA Credit Agreement was $335.0 million, including (i) $150.0 million of Amended Tranche A Loans, (ii) $70.0 million of Amended Tranche A‑1 Loans and (iii) $115.0 million of Amended Revolving Loans. The loans under the Amended BoA Credit Agreement bear interest, at the Company’s option, at a rate equal to (i) with respect to the Amended Revolving Loans and the Amended Tranche A Loans (a) the LIBOR rate plus 3.50% per annum or (b) the base rate plus 2.50% per annum and (ii) with respect to the Amended Tranche A‑1 Loans (a) the LIBOR rate plus 7.00% per annum or (b) the base rate plus 6.00% per annum. The loans under the Amended BoA Credit Agreement provide for interest rate reductions if certain leverage ratios are achieved, with minimum interest rates equal to (i) with respect to the Amended Revolving Loans and the Amended Tranche A Loans (a) the LIBOR rate plus 3.00% per annum or (b) the base rate plus 2.00% per annum and (ii) with respect to the Amended Tranche A-1 Loans (a) the LIBOR rate plus 6.00% per annum or (b) the base rate plus 5.00% per annum. The undrawn portions of the Revolving Credit Commitments are subject to a commitment fee of 0.375% per annum. As of September 30, 2019, we had $24.4 million available under the current revolving credit facility (the “Revolving Credit Facility”) . The Company may make voluntary prepayments of the loans outstanding under the Amended BoA Credit Agreement, subject to the payment of customary “breakage” costs with respect to LIBOR-based borrowings and, in certain cases, to the prepayment premium set forth in the Amended BoA Credit Agreement. Additionally, the Company is mandated to make prepayments (without payment of a premium or penalty) under the Amended BoA Credit Agreement amounting to: (i) the loans outstanding under the Amended BoA Credit Agreement plus, (a) where intellectual property is disposed, 50.0% of the disposed intellectual property’s orderly liquidation value, and (b) where any other assets constituting collateral are disposed or upon the receipt of certain insurance proceeds, 100% of the net proceeds thereof, subject to certain reinvestment rights; and (ii) the Amended Tranche A-1 Loans to the extent that the outstanding principal amount thereof exceeds 15.0% of the orderly liquidation value of the registered trademarks owned by the BoA Facility Loan Parties. The Amended BoA Term Loans will continue to amortize in quarterly installments of $5.0 million. The Amended BoA Credit Agreement contains customary representations and warranties and customary affirmative and negative covenants applicable to the BoA Facility Loan Parties and their subsidiaries. Moreover, the Amended BoA Credit Agreement contains financial covenants that require the BoA Facility Loan Parties and their subsidiaries to (i) maintain a positive net income, (ii) satisfy a maximum loan to value ratio initially set at 50.0% (applicable to the Amended Revolving Loans and Amended Tranche A Loans) decreasing over the term of the Amended BoA Credit Agreement until reaching a final maximum loan to value ratio of 42.5% and (iii) satisfy a maximum consolidated first lien leverage ratio, initially set at 3.875:1:00, decreasing over the term of the Amended BoA Credit Agreement until reaching a final maximum ratio of 2.875:1.00 for the fiscal quarter ending September 30, 2022 and thereafter. The Amended BoA Credit Agreement contains certain customary events of default, including a change of control. If an event of default occurs and is not cured within any applicable grace period or not waived, the Bank of America Agent, at the request of the lenders under the Amended BoA Credit Agreement, must take various actions, including, without limitation, the acceleration of all amounts due under the Amended BoA Credit Agreement. The Company may request an increase in (i) the Revolving Credit Facility and Tranche A Loans as would not cause the consolidated first lien leverage ratio, determined on a pro forma basis after giving effect to any such increase, to exceed 2.80:1.00 and (ii) the Tranche A-1 Loans, as would not cause the consolidated first lien leverage ratio, determined on a pro forma basis after giving effect to any such increase, to exceed (a) with respect to any increase, the proceeds of which will be used solely to finance an acquisition, 3.00:1.00 and (b) with respect to any other increase, 2.90:1.00, subject to the satisfaction of certain conditions in the Amended BoA Credit Agreement. At September 30, 2019, the Company is in compliance with the covenants included in the Amended BoA Credit Agreement. The Amended FS/KKR Credit Agreement provides for a five and a half-year $314.0 million senior secured term loan facility. The Company may request one or more additional term loan facilities or the increase of term loan commitments under the Amended FS/KKR Credit Agreement as would not have caused the consolidated total leverage ratio, determined on a pro forma basis after giving effect to any such addition and increase, to exceed 6.00:1.00, subject to the satisfaction of certain conditions in the Amended FS/KKR Credit Agreement. The loans under the Amended FS/KKR Credit Agreement bear interest, at the Company’s option, at a rate equal to either (i) the LIBOR rate plus 8.75% per annum or (ii) the base rate plus 7.75% per annum. The Company may make voluntary prepayments of the loans outstanding under the Amended FS/KKR Credit Agreement, subject to the payment of customary “breakage” costs with respect to LIBOR-based borrowings and, in certain cases, to the prepayment premium set forth in the Amended FS/KKR Credit Agreement. The Company is mandated to make prepayments (without payment of a premium or penalty) of loans outstanding under the Amended FS/KKR Credit Agreement amounting to: (i) where intellectual property was disposed, 50.0% of the disposed intellectual property’s orderly liquidation value, (ii) where any other asset constituting collateral is disposed or upon the receipt of certain insurance proceeds, 100% of the net proceeds thereof, subject to certain reinvestment rights, and (iii) any consolidated excess cash flow, in an amount equal to (a) in the event the consolidated total leverage ratio was at least 4.00:1.00, 75% thereof, (b) in the event the consolidated total leverage ratio was less than 4.00:1.00 but at least 3.00:1.00, 50% thereof and (c) in the event the consolidated total leverage ratio was less than 3.00:1.00, 0% thereof. N o mandatory amortization payments are required until September 30, 2020. Thereafter, the loans under the Amended KKR/FS Credit Agreement will be subject to quarterly amortization payments of $1.0 million. The Amended FS/KKR Credit Agreement contains customary representations and warranties and customary affirmative and negative covenants applicable to the FS/KKR Facility Loan Parties and their subsidiaries. Moreover, the Amended FS/KKR Credit Agreement contains financial covenants that require the FS/KKR Facility Loan Parties and their subsidiaries to satisfy (i) a maximum consolidated total leverage ratio, initially set at 7.25:1.00, decreasing over the term of the Amended FS/KKR Credit Agreement until reaching a final maximum ratio of 6.25:1.00 for the fiscal quarter ending September 30, 2022 and thereafter and (ii) a maximum consolidated first lien leverage ratio, initially set at 3.875:1.00, decreasing over the term of the Amended FS/KKR Credit Agreement until reaching a final maximum ratio of 2.875:1.00 for the fiscal quarter ending September 30, 2022 and thereafter. At September 30, 2019, the Company is in compliance with the covenants included in the Amended FS/KKR Credit Agreement. The Amended FS/KKR Credit Agreement contains certain customary events of default, including a change of control. If an event of default occurs and is not cured within any applicable grace period or is not waived, the FS/KKR Agent, at the request of the lenders under the Amended FS/KKR Credit Agreement, is required to take various actions, including, without limitation, the acceleration of amounts due thereunder. The Company may request one or more additional term loan facilities or the increase of term loan commitments under the Amended FS/KKR Credit Agreement as would not have caused the consolidated total leverage ratio, determined on a pro forma basis after giving effect to any such addition and increase, to exceed 6.00:1.00, subject to the satisfaction of certain conditions in the Amended FS/KKR Credit Agreement. Interest Rate Swaps On December 10, 2018, the Company entered into interest rate swap agreements related to its term loans (the “2018 Swap Agreements”) with certain financial institutions. The Company recorded its interest rate swaps in accrued expense and other long-term liabilities on the condensed consolidated balance sheets at fair value using Level 2 inputs. The 2018 Swap Agreements have a $300 million notional value, and $150 million matures on December 31, 2021 and $150 million matures on January 4, 2022. The Company’s risk management objective and strategy with respect to the 2018 Swap Agreements is to reduce its exposure to variability in cash flows on a portion of the Company’s floating-rate debt. The 2018 Swap Agreements protect the Company from changes in its cash flows attributable to changes in a contractually specified interest rate on an amount of borrowing equal to the then outstanding swap notional. The Company periodically assesses the effectiveness of the hedges (both prospective and retrospective) by performing a single regression analysis that was prepared at the inception of the hedging relationship. To the extent a hedging relationship is highly effective, the gain or loss on the swap will be recorded in accumulated other comprehensive loss and reclassified into interest expense in the same period during which the hedged transactions affect earnings. During the nine months ended September 30, 2019, the Company determined that a portion of one of the hedges was no longer effective due to the repayment of certain debt with the proceeds from the sale of MSLO. As a result, in accordance with ASC 815-30-40-6A, the Company de-designated it as a cash flow hedge and reclassified a loss of $0.4 million from other comprehensive loss to other expense in the unaudited condensed consolidated statements of operations. Changes in the fair value of the de-designated interest rate swap after the de-designation date are being recognized through continuing operations. The Company recorded a loss of $0.4 million and $0.9 million in other expense from continuing operations in the unaudited condensed consolidated statements of operations for the three and nine months ended September 30, 2019, respectively.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2019
Commitments and Contingencies [Abstract]
Commitments and Contingencies	9. Commitments and Contingencies General Legal Matters From time to time, the Company is involved in legal matters arising in the ordinary course of business. While the Company believes that such matters are currently not material, there can be no assurance that matters arising in the ordinary course of business for which the Company is, or could be, involved in litigation, will not have a material adverse effect on its business, financial condition or results of operations. Contingent liabilities arising from potential litigation are assessed by management based on the individual analysis of these proceedings and on the opinion of the Company’s lawyers and legal consultants.

Stock-based Compensation

Stock-based Compensation	9 Months Ended
	Sep. 30, 2019
Stock-based Compensation
Stock-based Compensation	10. Stock-based Compensation Stock Options The following table summarizes the Company’s stock option activity for the nine months ended September 30, 2019: Weighted-Average Remaining Number of Weighted-Average Contractual Life Aggregate Options Exercise Price (in Years) Intrinsic Value (in thousands, except share and per share data) Outstanding - January 1, 2019 49,501 $ 10.22 2.3 $ — Granted — — Exercised — — Forfeited or canceled (10,000) (13.68) Outstanding at September 30, 2019 39,501 $ 9.34 2.0 $ — Exercisable - September 30, 2019 39,501 $ 9.34 2.0 $ — There was no compensation expense related to stock options for the three and nine months ended September 30, 2019 and 2018. At September 30, 2019, there is no unrecognized compensation expense related to stock options and no unvested stock options. Warrants The following table summarizes the Company’s outstanding warrants for the nine months ended September 30, 2019: Weighted-Average Remaining Number of Weighted-Average Contractual Life Aggregate Warrants Exercise Price (in Years) Intrinsic Value (in thousands, except share and per share data) Outstanding - January 1, 2019 200,000 $ 13.32 6.4 $ — Granted — — Exercised — — Forfeited or canceled — — Outstanding at September 30, 2019 200,000 $ 13.32 5.7 $ — Exercisable - September 30, 2019 200,000 $ 13.32 5.7 $ — There was no compensation expense related to warrants for the three and nine months ended September 30, 2019 and 2018. At September 30, 2019, there is no unrecognized compensation expense related to warrants and no unvested warrants. Restricted Stock A summary of the Company’s time-based restricted stock activity for the nine months ended September 30, 2019 is as follows: Weighted-Average Weighted-Average Remaining Grant Date Fair Contractual Life Number of Shares Value (in Years) Unvested - January 1, 2019 292,989 $ 3.72 0.9 Granted 464,576 0.86 Vested (235,296) (1.70) Unvested - September 30, 2019 522,269 $ 0.85 0.8 During the nine months ended September 30, 2019, the Company granted 464,576 shares of time-based restricted stock to members of the Company’s board of directors. These shares had a grant date fair value of $0.4 million and vest over a period of one year. The Company recorded $0.1 million and $0.2 million during the three and nine months ended September 30, 2019, respectively, as compensation expense from continuing operations pertaining to these grants. During the nine months ended September 30, 2018, the Company granted 235,296 shares of time-based restricted stock to members of the Company’s board of directors. These shares had a grant date fair value of $0.4 million and vest over a period of one year. The Company recorded $0.1 million during the nine months ended September 30, 2019 as compensation expense from continuing operations pertaining to these grants. The Company recorded $0.1 million and $0.2 million during the three and nine months ended September 30, 2018 as compensation expense from continuing operations pertaining to these grants. Total compensation expense from continuing operations related to time-based restricted stock grants for each of the three months ended September 30, 2019 and 2018 was $0.1 million. Total compensation expense from continuing operations related to time-based restricted stock grants for each of the nine months ended September 30, 2019 and 2018 was $0.3 million and $0.4 million, respectively. Total unrecognized compensation expense from continuing operations related to time-based restricted stock grants at September 30, 2019 amounted to $0.3 million and is expected to be recognized over a weighted-average period of 0.8 years. Restricted Stock Units A summary of the Company’s time-based restricted stock units activity for the nine months ended September 30, 2019 is as follows: Weighted-Average Weighted-Average Remaining Grant Date Fair Contractual Life Number of Shares Value (in Years) Unvested - January 1, 2019 1,615,953 $ 2.24 2.2 Granted — — Vested (574,582) (2.85) Forfeited or canceled (40,000) (1.76) Unvested - September 30, 2019 1,001,371 $ 1.25 1.3 The Company did not grant time-based restricted stock units during the three and nine months ended September 30, 2019. During the nine months ended September 30, 2018, the Company granted 1,635,257 time-based restricted stock units to certain employees and consultants for future services. These shares of time-based restricted stock units had a grant date fair value of $3.0 million and vest immediately to over a period of five years. The Company recorded $0.2 million during the three months ended September 30, 2018 as compensation expense from continuing operations pertaining to these grants. The Company recorded $0.1 million and $0.7 million during the nine months ended September 30, 2019 and 2018, respectively, as compensation expense from continuing operations pertaining to these grants. During the nine months ended September 30, 2018, the Company issued 843,486 time-based restricted stock units to an employee for a 2017 performance-based bonus pursuant to their employment agreement. The bonus was paid in restricted stock in the first quarter of 2018, based on the average closing stock price for the 30 days preceding March 1, 2018. Compensation expense was fully recognized in 2017 related to this grant. Total compensation expense from continuing operations related to time-based restricted stock unit grants for the three months ended September 30, 2019 and 2018 was less than $0.1 million and $0.4 million, respectively. Total compensation expense from continuing operations related to time-based restricted stock unit grants for the nine months ended September 30, 2019 and 2018 was $0.7 million and $1.4 million, respectively. Total unrecognized compensation expense from continuing operations related to time-based restricted stock unit grants at September 30, 2019 amounted to $0.9 million and is expected to be recognized over a weighted-average period of 1.3 years. Performance Stock Units A summary of the Company’s PSUs activity for the nine months ended September 30, 2019 is as follows: 0 Weighted-Average Weighted-Average Remaining Grant Date Fair Contractual Life Number of Shares Value (in Years) Unvested - January 1, 2019 2,219,818 $ 4.47 0.8 Granted — — Vested (289,671) (4.68) Forfeited or canceled (511,491) (6.59) Unvested - September 30, 2019 1,418,656 $ 3.66 0.9 On March 27, 2019, the Compensation Committee voted to approve, on a discretionary basis, vesting of 231,396 PSUs to employees and consultants previously granted during the years ended December 31, 2016, 2017 and 2018 subject to achievement of certain of the Company’s performance metrics within each fiscal year. The fair value and expense recorded for such PSUs was based on the closing price of the Company’s common stock on the date the modification of the performance metric was communicated to employees and consultants. Total compensation expense related to these PSUs of $0.2 million was recorded as operating expenses from continuing operations in the unaudited condensed consolidated statements of operations for the nine months ended September 30, 2019. During the nine months ended September 30, 2018, the Company granted 135,000 PSUs to employees pursuant to their employment agreements. These PSUs had a grant date fair value of $0.3 million, vest over a period of one to two years and require achievement of certain performance metrics within each fiscal year for such PSUs to be earned. The Company issued 83,250 PSUs to an employee related to this grant. The fair value and expense recorded for such PSUs was based on the closing price of the Company’s common stock on the date the performance metric was communicated to the employee. The Company recorded $0.2 million in compensation expense related to these PSUs during the three and nine months ended September 30, 2018 as operating expenses from continued operations in the unaudited condensed consolidated statements of operations. During the nine months ended September 30, 2018, the Company granted 200,000 PSUs to an employee upon their commencement of employment with the Company. These PSUs had a grant date fair value of $0.5 million, vest over a period of two years and require achievement of certain of the Company’s performance metrics within each fiscal year for such PSUs to be earned. The Company did not record any compensation expense during the three and nine months ended September 30, 2019 and 2018 as the likelihood of these PSUs being earned was not considered probable. During the nine months ended September 30, 2018, the Company granted 250,000 PSUs to a consultant pursuant to their endorsement agreement. The PSUs had a grant date fair value of $0.5 million, vest over a period of five years and require achievement of certain sales targets within each fiscal year for such PSUs to be earned. The Company did not record any compensation expense during the three and nine months ended September 30, 2019 and 2018 as the likelihood of these PSUs being earned was not considered probable. On February 20, 2018, the Compensation Committee voted to approve, on a discretionary basis, vesting of 208,883 PSUs to employees and consultants previously granted during the years ended December 31, 2016 and 2017 subject to achievement of certain of the Company’s performance metrics within each fiscal year. The fair value and expense recorded for such PSUs was based on the closing price of the Company’s common stock on the date the modification of the performance metric was communicated to employees and consultants. Total compensation expense from continuing operations related to these PSUs of $0.5 million was recorded as operating expenses from continuing operations in the unaudited condensed consolidated statements of operations for the nine months ended September 30, 2018. No compensation expense was recorded for the three months ended September 30, 2019 due to the achievement of performance metrics not being deemed probable. Total compensation expense from continuing operations related to the PSUs for the three months ended September 30, 2018 was $0.2 million. Total compensation expense from continuing operations related to the PSUs for the nine months ended September 30, 2019 and 2018 was $0.2 million and $0.8 million, respectively.

Related Party Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2019
Related Party Transactions [Abstract]
Related Party Transactions	11. Related Party Transactions Consulting Services Agreement with Tengram Capital Partners, L.P. (f/k/a Tengram Capital Management L.P.) Pursuant to an agreement with Tengram Capital Partners, L.P., formerly known as Tengram Capital Management, L.P. (“TCP”), an affiliate of Tengram Capital Partners Gen2 Fund, L.P., which is one of the Company’s largest stockholders, the Company has engaged TCP, effective as of January 1, 2013, to provide services to the Company pertaining to (i) mergers and acquisitions, (ii) debt and equity financing and (iii) such other related areas as the Company may reasonably request from time to time (the “TCP Agreement”). The TCP Agreement remains in effect for a period continuing through the earlier of five years or the date on which TCP and its affiliates cease to own in excess of 5% of the outstanding shares of common stock in the Company. On August 15, 2014, the Company consummated transactions pursuant to an agreement and plan of merger, dated as of June 24, 2014 (the “Galaxy Merger Agreement”) with SBG Universe Brands LLC, a Delaware limited liability company and the Company’s direct wholly-owned subsidiary (“LLC Sub”), Universe Galaxy Merger Sub, Inc., a Delaware corporation and direct wholly-owned subsidiary of LLC Sub, Galaxy Brand Holdings, Inc. and Carlyle Galaxy Holdings, L.P. (such transactions, collectively, the “Galaxy Acquisition”). In connection with the Galaxy Merger Agreement, the Company and TCP entered into an amendment to the TCP Agreement (the “Amended TCP Agreement”), pursuant to which, among other things, TCP is entitled to receive annual fees of $0.9 million beginning with fiscal 2014. The Company paid TCP $0.2 million for services under the Amended TCP Agreement during each of the three-month periods ended September 30, 2019 and 2018. The Company paid TCP $0.7 million for services under the Amended TCP Agreement during each of the nine-month periods ended September 30, 2019 and 2018. At September 30, 2019 and December 31, 2018, there were $0.2 million due to TCP for services. The Company paid $1.8 million in transaction fees to TCP related to the sale of MSLO during the nine months ended September 30, 2019. Additionally, in July 2013, the Company entered into a consulting arrangement with an employee of TCP (the “TCP Employee”), pursuant to which the TCP Employee provides legal and other consulting services at the request of the Company from time to time. The TCP Employee was also issued 125,000 shares of restricted stock, vesting over a four-year period and 180,000 PSUs, vesting over three years in increments of 20% for 2014, 20% for 2015 and 60% for 2016. In 2016, the TCP employee was granted 200,000 PSUs, vesting over three years in increments of 33.3% for 2017, 33.3% for 2018 and 33.4% for 2019. In 2018, the TCP employee was granted 150,000 shares of time-based restricted stock units, vesting over a three year period and 300,000 shares of time-based restricted stock units, vesting over a three year period with 25% vesting immediately. The Company paid the TCP Employee $0.1 million for services under the consulting arrangement during each of the three-month periods ended September 30, 2019 and 2018. The Company paid the TCP Employee $0.2 million for services under the consulting arrangement during each of the nine-month periods ended September 30, 2019 and 2018. These amounts are included in operating expenses from continuing operations in the Company’s unaudited condensed consolidated financial statements. At September 30, 2019, no amounts were due to the TCP Employee. The Company and the TCP Employee terminated the consulting arrangement during the three months ended September 30, 2019. At December 31, 2018, less than $0.1 million was due to the TCP Employee. Investment in Equity Securities In September 2015, the Company purchased equity securities of Iconix Brand Group, Inc., an unaffiliated third-party publicly traded company, from Tengram Capital Partners, L.P., which is an affiliate of Tengram Capital Partners Gen2 Fund, L.P., one of the Company’s largest stockholders, for an aggregate purchase price of $12.0 million (plus related transaction expenses), which was the purchase price paid by Tengram Capital Partners, L.P. upon the acquisition of such equity securities in open market transactions. The Company did not pay a fee or any compensation to Tengram Capital Partners, L.P. in connection with the Company’s investment in the equity securities. The Company sold these equity securities during the year ended December 31, 2017. Transactions with Tommie Copper, Inc. The Company entered into an agreement with Tommie Copper, Inc. (“TCI”), an affiliate of TCP, under which the Company received a fee for facilitating certain distribution arrangements. The Company recorded $3.1 million of revenue from continuing operations for the nine months ended September 30, 2018. At December 31, 2018, the Company had a current receivable of $1.1 million from TCI in accounts receivable and a long-term receivable of $1.9 million from TCI in other assets in the unaudited condensed consolidated balance sheets. During the three months ended September 30, 2019, the Company wrote off $2.7 million related to the outstanding receivable balance recorded in operating expenses from continuing operations in the unaudited condensed consolidated statements of operations as TCI could not adhere to its original payment terms and new extended payment terms have been negotiated. At September 30, 2019, the Company had a current receivable of $0.1 million due from TCI. Transactions with E.S. Originals, Inc. A division president of the Company maintains a passive ownership interest in one of the Company’s licensees, E.S. Originals, Inc. (“ESO”). The Company receives royalties from ESO under license agreements for certain of the Company’s brands in the footwear category. The Company recorded $1.2 million and $3.1 million of revenue from continuing operations for the three months ended September 30, 2019 and 2018, respectively, for royalties, commission, and advertising revenue earned from ESO license agreements. The Company recorded $3.7 million and $6.6 million of revenue from continuing operations for the nine months ended September 30, 2019 and 2018, respectively, for royalties, commission, and advertising revenue earned from ESO license agreements. At September 30, 2019 and December 31, 2018, the Company had $4.8 million and $6.2 million, respectively, as accounts receivable and $0.5 million and $1.9 million, respectively, as a long-term receivable in other assets from ESO in the condensed consolidated balance sheets. In addition, the Company entered into a license-back agreement with ESO under which the Company reacquired the rights to certain international territories in order to re-license these rights to an unrelated party. The Company recorded less than $0.1 million in license-back expense from continuing operations for each of the three months ended September 30, 2019 and 2018. The Company recorded $0.2 million in license-back expense from continuing operations for each of the nine months ended September 30, 2019 and 2018. Transactions with Centric Brands Inc. (f/k/a Differential Brands Group, Inc.) During the fourth quarter of 2018, Centric Brands, Inc. (“Centric”) , an affiliate of TCP, acquired a significant portion of Global Brands Group Holding Limited’s (“GBG”) North American licensing business. The Company recorded approximately $1.6 million and $4.8 million for royalty revenue earned from the Centric license agreement for the three and nine months ended September 30, 2019. At September 30, 2019, no amounts were due from Centric. At December 31, 2018, the Company had $0.8 million recorded as accounts receivable from Centric in the condensed consolidated balance sheets. At September 30, 2019, the Company had accrued $0.5 million payable as accounts payable and accrued expenses to Centric in the unaudited condensed consolidated balance sheet. Acquisition of FUL On November 17, 2014, the Company made a strategic investment in FUL IP. FUL IP is a collaborative investment between the Company and JALP. FUL IP was formed for the purpose of licensing the FUL trademark to third parties in connection with the manufacturing, distribution, marketing and sale of FUL branded bags, backpacks, duffels, luggage and apparel accessories. JALP contributed the FUL trademark with a fair value of $8.9 million. In exchange for a 50.5% economic interest in FUL IP, the Company paid JALP $4.5 million. JALP’s minority member interest in FUL IP has been reflected as noncontrolling interest on the Company’s condensed consolidated balance sheets. One of the Company’s directors, Mr. Al Gossett, has a partial ownership interest in JALP. The Company sold the FUL trademark and incurred a loss on the sale of the trademark of $2.0 million during the year ended December 31, 2018. No noncontrolling interest was recorded during the three and nine months ended September 30, 2019. No noncontrolling interest was recorded during the three months ended September 30, 2018. There was $0.7 million of noncontrolling interest loss recorded during the nine months ended September 30, 2018 in continuing operations. IP License Agreement and Intangible Asset Agreement On June 10, 2019, the Company completed the sale of MSLO. As a result, accounts payable and accrued expenses decreased by $2.8 million and other long-term liabilities decreased by $1.1 million which was recorded within assets classified as held for disposition from discontinued operations as of December 31, 2018. In connection with the transactions contemplated by the previous acquisition of MSLO (the “Mergers”), MSLO entered into an Amended and Restated Asset License Agreement (“Intangible Asset Agreement”) and Amended and Restated Intellectual Property License and Preservation Agreement (“IP License Agreement” and, together with the Intangible Asset Agreement, the “IP Agreements”) pursuant to which Ms. Martha Stewart licensed certain intellectual property to MSLO. The IP Agreements granted the Company the right to use of certain properties owned by Ms. Stewart. The Intangible Asset Agreement had an initial term commencing at December 4, 2015 and ending on December 31, 2020, provided that the term will automatically be renewed for five additional calendar years ending December 31, 2025 (subject to earlier termination as provided in Ms. Stewart’s employment agreement) if either the aggregate gross licensing revenues (as defined in Ms. Stewart’s employment agreement) for calendar years 2018 through 2020 exceed $195 million or the gross licensing revenues for calendar year 2020 equal or exceed $65 million. During the term of the Intangible Asset Agreement with the Company, Lifestyle Research Center LLC will be entitled to receive a guaranteed annual payment of $1.7 million, which amounts are being paid in connection with the Mergers regardless of Ms. Stewart’s continued employment with the Company plus reimbursable expenses. The Company has paid Lifestyle Research Center LLC less than $0.1 million in connection with other related services during the three months ended September 30, 2018, which is recorded in discontinued operations on the unaudited condensed consolidated statement of operations. The Company has paid Lifestyle Research Center LLC $0.8 million and $0.3 million in connection with other related services during the nine months ended September 30, 2019 and 2018, respectively, which is recorded in discontinued operations on the unaudited condensed consolidated statement of operations. During the term of the IP License Agreement with the Company, Ms. Stewart was entitled to receive a guaranteed annual payment of $1.3 million, which amounts were being paid in connection with the Mergers regardless of Ms. Stewart’s continued employment with the Company. During the three months ended September 30, 2018 the Company made payments of $0.3 million to Ms. Stewart in connection with the terms of the IP License Agreement. During the nine months ended September 30, 2019 and 2018, the Company made payments of $0.6 million and $1.0 million to Ms. Stewart in connection with the terms of the IP License Agreement. The IP License Agreement with the Company ended as of June 10, 2019. During the three months ended September 30, 2018, the Company expensed non-cash interest of $0.1 million related to the accretion of the present value of these guaranteed contractual payments, which is recorded in discontinued operation on the unaudited condensed consolidated statements of operations. During the nine months ended September 30, 2019 and 2018, the Company expensed non-cash interest of $0.1 million and $0.3 million, respectively, related to the accretion of the present value of these guaranteed contractual payments, which is recorded in discontinued operations on the unaudited condensed consolidated statements of operations.

Subsequent Event

Subsequent Event	9 Months Ended
	Sep. 30, 2019
Subsequent Events
Subsequent Events	12. Subsequent Events On October 24, 2019, a licensee for Avia exercised a purchase option in their existing license agreement to acquire ownership of the Avia trademark registered in China for $12.3 million, effective as of January 15, 2020. The $12.3 million is payable in installments over a period of three years as follows: $3.3 million on June 30, 2020, $5.0 million on June 30, 2021 and $4.0 million on June 30, 2022. In the event the licensee fails to pay the purchase price in full the trademark reverts to the Company. The exercising of the purchase option will not have a material impact on the Company’s consolidated financial statements as the proceeds from the sale will be applied against the cost basis of the intangible asset on the Company’s consolidated balance sheet in the fourth quarter of 2019.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2019
Summary of Significant Accounting Policies [Abstract]
Basis of presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the instructions to Form 10‑Q and Rule 10‑01 of Regulation S-X of the United States Securities and Exchange Commission (the “SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all of the information and footnotes necessary for a comprehensive presentation of financial position, results of operations or cash flows. It is the Company’s opinion, however, that the accompanying unaudited condensed consolidated financial statements include all adjustments, which are of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10‑K for the year ended December 31, 2018, as filed with the SEC on March 14, 2019, which contains the audited consolidated financial statements and notes thereto, together with Management’s Discussion and Analysis of Financial Condition and Results of Operations, for the years ended December 31, 2018, 2017 and 2016. The financial information as of December 31, 2018 is derived from the audited consolidated financial statements presented in the Company’s Annual Report on Form 10‑K for the year ended December 31, 2018. The interim results for September 30, 2019 are not necessarily indicative of the results to be expected for the year ending December 31, 2019 or for any future interim periods.
Reclassification of Prior Year Presentation	Reclassification of Prior Periods On June 10, 2019, the Company completed the sale of Martha Stewart Living Omnimedia, Inc. (“MSLO”), a Delaware corporation and a wholly-owned subsidiary of the Company, for $166 million in cash consideration, plus additional amounts in respect of pre-closing accounts receivable that are received after the closing, subject to certain adjustments, pursuant to an equity purchase agreement (the “Purchase Agreement”) with Marquee Brands LLC (the “Buyer”) entered into on April 16, 2019. In addition, the Purchase Agreement provides for an earnout of up to $40,000,000 if certain performance targets are achieved during the three calendar years ending December 31, 2020, December 31, 2021 and December 31, 2022. MSLO and its subsidiaries were engaged in the business of promoting, marketing and licensing the Martha Stewart and the Emeril Lagasse brands through various distribution channels. Due to the sale of MSLO during the second quarter of 2019 (see Note 3), in accordance with Accounting Standards Codification (“ASC”) 205, Discontinued Operations , we have classified the results of MSLO as discontinued operations in our unaudited condensed consolidated statements of operations and cash flows for all periods presented. Additionally, the related assets and liabilities directly associated with MSLO are classified as held for disposition from discontinued operations in our condensed consolidated balance sheets for all periods presented. All amounts included in the notes to the condensed consolidated financial statements relate to continuing operations unless otherwise noted.
Principles of Consolidation	Principles of Consolidation The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly-owned and majority-owned subsidiaries. All significant inter-company accounts and transactions have been eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the unaudited condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the unaudited condensed consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from estimates.
Revenue Recognition	Revenue Recognition The Company recognizes revenue in accordance with ASC 606, Revenue from Contracts with Customers (“ASC 606”), which became effective for the Company as of January 1, 2018. ASC 606 requires a five-step approach to determine the appropriate method of revenue recognition for each contractual arrangement: Step 1: Identify the Contract(s) with a Customer Step 2: Identify the Performance Obligation(s) in the Contract Step 3: Determine the Transaction Price Step 4: Allocate the Transaction Price to the Performance Obligation(s) in the Contract Step 5: Recognize Revenue when (or as) the Entity Satisfies a Performance Obligation The Company has entered into various license agreements for its owned trademarks. Under ASC 606, the Company’s agreements are generally considered symbolic licenses, which contain the characteristics of a right-to-access license since the customer is simultaneously receiving the intellectual property (“IP”) and benefiting from it throughout the license period. The Company assesses each license agreement at inception and determines the performance obligation(s) and appropriate revenue recognition method. As part of this process, the Company applies judgments based on historical trends when estimating future revenues and the period over which to recognize revenue. The Company generally recognizes revenue for license agreements under the following methods: 1. Licenses with guaranteed minimum royalties (“GMRs”) : Generally, guaranteed minimum royalty payments (fixed revenue) comprising the transaction price are recognized on a straight-line basis over the term of the contract, as defined in each license agreement. 2. Licenses with both GMRs (fixed revenue) and earned royalties (variable revenue) : Earned royalties in excess of fixed revenue are only recognized when the Company is reasonably certain that the guaranteed minimum payments for the period, as defined in each license agreement, will be exceeded. Additionally, the Company has categorized certain contracts as variable when there is a history and future expectation of exceeding GMRs. The Company recognizes income for these contracts during the period corresponding to the licensee’s sales. 3. Licenses that are sales-based only or earned royalties : Earned royalties (variable revenue) are recognized as income during the period corresponding to the licensee’s sales. Payments received as consideration for the grant of a license or advanced royalty payments are recorded as deferred revenue at the time payment is received and recognized into revenue under the methods described above. Contract assets represent unbilled receivables and are presented within accounts receivable, net on the condensed consolidated balance sheets. Contract liabilities represent unearned revenues and are presented within the current portion of deferred revenue on the condensed consolidated balance sheets. The Company disaggregates its revenue from continuing operations into two categories: licensing agreements and other, which is comprised of revenue from sources such as sales commissions and vendor placement commissions. Commission revenues and vendor placement commission revenues are recorded in the period the commission is earned.
Restricted Cash	Restricted Cash Restricted cash consists of cash deposited with a financial institution required as collateral for the Company’s cash-collateralized letter of credit facilities.
Accounts Receivable	Accounts Receivable Accounts receivable are recorded net of allowances for doubtful accounts, based on the Company’s ongoing discussions with its licensees and other customers and its evaluation of their creditworthiness, payment history and account aging. Accounts receivable balances deemed to be uncollectible are written off after all means of collection have been exhausted and the potential for recovery is considered remote. The allowance for doubtful accounts was $1.9 million and $1.8 million as of September 30, 2019 and December 31, 2018, respectively. On June 10, 2019, the Company completed the sale of MSLO. As a result, accounts receivable, net, decreased $16.6 million which was recorded within current assets classified as held for disposition from discontinued operations as of December 31, 2018. The Company’s accounts receivable, net amounted to $41.4 million and $49.6 million as of September 30, 2019 and December 31, 2018, respectively. Two licensees accounted for approximately 49% (32% and 17%) of the Company’s total consolidated accounts receivable balance as of September 30, 2019 and two licensees accounted for approximately 41% (25%, and 16%) of the Company’s total consolidated accounts receivable balance as of December 31, 2018. The Company does not believe the accounts receivable balance from these licensees represents a significant collection risk based on past collection experience.
Investments	Investments The Company accounts for equity securities under ASC 321, Investments – Equity Securities (“ASC 321”). Such securities are reported at fair value in the condensed consolidated balance sheets and, at the time of purchase, are reported in the condensed consolidated statements of cash flows as an investing activity. Gains and losses on equity securities are recognized through continuing operations. The Company recognized a loss on its equity securities of $0.4 million and $0.1 million recorded in other expense from continuing operations on the condensed consolidated statements of operations for the three and nine months ended September 30, 2019, respectively. No gain or loss was recorded in other income for the three and nine months ended September 30, 2018.
Equity Method Investment	Equity Method Investment For investments in entities over which the Company exercises significant influence but which do not meet the requirements for consolidation, the Company uses the equity method of accounting. On July 1, 2016, the Company acquired a 49.9% noncontrolling interest in Gaiam Pty. Ltd. in connection with its acquisition of Gaiam Brand Holdco, LLC, which is included in other assets in the condensed consolidated balance sheets. The Company’s share of earnings from its equity method investee, which was not material for the three and nine months ended September 30, 2019 and 2018, is included in other income from continuing operations in the unaudited condensed consolidated statements of operations. The Company evaluates its equity method investment for impairment whenever events or changes in circumstances indicate that the carrying amounts of such investment may not be recoverable. The difference between the carrying value of the equity method investment and its estimated fair value is recognized as an impairment charge when the loss in value is deemed other-than-temporary.
Intangible Assets	Intangible Assets On an annual basis (October 1 st ) and as needed, the Company tests indefinite lived trademarks for impairment through the use of discounted cash flow models. Assumptions used in the Company’s discounted cash flow models include: (i) discount rates; (ii) projected average revenue growth rates; and (iii) projected long-term growth rates. The Company’s estimates also factor in economic conditions and expectations of management, which may change in the future based on period-specific facts and circumstances. Other intangibles with determinable lives, including certain trademarks, customer agreements and patents, are evaluated for the possibility of impairment when certain indicators are present, and are otherwise amortized on a straight-line basis over the estimated useful lives of the assets (currently ranging from 2 to 15 years). On June 10, 2019, the Company completed the sale of MSLO. As a result, indefinite-lived intangible assets decreased by $330.1 million which was recorded within assets classified as held for disposition from discontinued operations as of December 31, 2018. During the first quarter of 2019, the Company recorded non-cash impairment charges of $161. 2 million for indefinite-lived intangible assets related to the Martha Stewart and Emeril Lagasse trademarks. The impairments arose as a result of the sale process for the Martha Stewart and Emeril Lagasse brands (as discussed in Note 3) due to the difference in the fair value as indicated by the sales price as compared to the carrying values of the intangible assets included in the transaction. The sale of the Martha Stewart and Emeril Lagasse brands was approved by the Board of Directors on April 15, 2019, to allow the Company to achieve one of its top priorities in significantly reducing its debt. Going forward the Company’s strategy is to focus on higher margin brands that are well suited for growing health, wellness and beauty categories. These charges are included in discontinued operations in the unaudited condensed consolidated statements of operations. See Note 3 and Note 7. During the three months ended September 30, 2019, the Company recorded non-cash impairment charges of $33.1 million consisting of $28.5 million related to the Jessica Simpson trademark and $4.6 million related to the Joe’s trademark. During the three months ended September 30, 2018, the Company recorded non-cash impairment charges of $17.9 million for indefinite-lived intangible assets related to two of the Company’s non-core brands: Ellen Tracy and Caribbean Joe . The impairments arose due to reduced growth expectations and the impact of licensee transitions for these brands. Fair value for each trademark was determined based on the income approach using estimates of future discounted cash flows. These charges are included in impairment charges in the unaudited condensed consolidated statements of operations. See Note 4 and Note 7.
Treasury Stock	Treasury Stock Treasury stock is recorded at cost as a reduction of equity in the condensed consolidated balance sheets.
Stock-Based Compensation	Stock-Based Compensation Compensation cost for restricted stock is measured using the quoted market price of the Company’s common stock at the date the common stock is granted. For restricted stock and restricted stock units, for which restrictions lapse with the passage of time (“time-based restricted stock”), compensation cost is recognized on a straight-line basis over the period between the issue date and the date that restrictions lapse. Time-based restricted stock is included in total shares of common stock outstanding upon the lapse of applicable restrictions. For restricted stock, for which restrictions are based on performance measures (“performance stock units” or “PSUs”), restrictions lapse when those performance measures have been deemed achieved. Compensation cost for PSUs is recognized on a straight-line basis during the period from the date on which the likelihood of the PSUs being earned is deemed probable and (x) the end of the fiscal year during which such PSUs are expected to vest or (y) the date on which awards of such PSUs may be approved by the compensation committee of the Company’s board of directors (the “Compensation Committee”) on a discretionary basis, as applicable. PSUs are included in total shares of common stock outstanding upon the lapse of applicable restrictions. PSUs are included in total diluted shares of common stock outstanding when the performance measures have been deemed achieved but the PSUs have not yet been issued. Fair value for stock options and warrants is calculated using the Black-Scholes valuation model and is expensed on a straight-line basis over the requisite service period of the grant. Compensation cost is reduced for forfeitures as they occur in accordance with Accounting Standards Update (“ASU”) 2016‑09, Simplifying the Accounting for Share-Based Payments (“ASU 2016‑09”) . The Company adopted ASU No. 2018-07, Improvements to Nonemployee Share-Based Payment Accounting (“ASU 2018-07”) as of January 1, 2019 on a modified retrospective basis. In accordance with ASU 2018-07, the Company recognizes compensation cost for grants to non-employees on a straight-line basis over the period of the grant. Prior periods have not been restated and were accounted for under the previous method where at each reporting period prior to the lapse of restrictions on warrants, time-based restricted stock and PSUs granted to non-employees, the Company remeasured the aggregate compensation cost of such grants using the Company’s fair value at the end of such reporting period and revised the straight-line recognition of compensation cost in line with such remeasured amount.
Leases	Leases The Company has operating leases for certain properties for its offices and showrooms and for copiers. The Company adopted ASU No. 2016-02, Leases (“ASU 2016-02” or “ASC 842”) as of January 1, 2019 using the modified retrospective method as of the period of adoption. The Company elected the package of practical expedients upon transition where the Company did not reassess the lease classification and initial direct costs for leases that existed prior to adoption. Additionally, the Company did not reassess contracts entered into prior to adoption to determine whether the arrangement was or contained a lease. In accordance with ASU 2016-02, for leases over twelve months the Company records a right-of-use asset and a lease liability representing the present value of future lease payments. Rent expense is recognized on a straight-line basis over the term of the lease. See Note 6 for further information.
Income Taxes	Income Taxes Current income taxes are based on the respective periods’ taxable income for federal, foreign and state income tax reporting purposes. Deferred tax liabilities and assets are determined based on the difference between the financial statement and income tax bases of assets and liabilities, using statutory tax rates in effect for the year in which the differences are expected to reverse. In accordance with ASU No. 2015‑17, Balance Sheet Classification of Deferred Taxes , all deferred income taxes are reported and classified as non-current. A valuation allowance is required if, based on the weight of available evidence, it is more likely than not that some portion or all of the deferred tax assets will not be realized. The Company applies the Financial Accounting Standards Board (“FASB”) guidance on accounting for uncertainty in income taxes. The guidance clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements in accordance with other authoritative GAAP and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. The guidance also addresses derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition. During the nine months ended September 30, 2019 and year ended December 31, 2018, the Company did not have any reserves or interest and penalties to record through current income tax expense in accordance with ASC 740, Income Taxes (“ASC 740”). Interest and penalties related to uncertain tax positions, if any, are recorded in income tax expense. Tax years that remain open for assessment for federal and state tax purposes include the years ended December 31, 2015 through December 31, 2018.
Earnings Per Share	Earnings Per Share Basic loss per share (“EPS”) attributable to Sequential Brands Group, Inc. and Subsidiaries is computed by dividing net loss attributable to Sequential Brands Group, Inc. and Subsidiaries by the weighted-average number of common shares outstanding during the reporting period, excluding the effects of any potentially dilutive securities. Diluted EPS gives effect to all potentially dilutive common shares outstanding during the reporting period, including stock options, PSUs and warrants, using the treasury stock method, and convertible debt, using the if-converted method. Diluted EPS excludes all potentially dilutive shares of common stock if their effect is anti-dilutive. B asic weighted-average common shares outstanding is equivalent to diluted weighted-average common shares outstanding for the three and nine months ended September 30, 2019 and 2018. Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 Basic weighted-average common shares outstanding 64,952,093 63,911,481 64,622,332 63,578,121 Performance based restricted stock — — — — Unvested restricted stock — — — — Diluted weighted-average common shares outstanding 64,952,093 63,911,481 64,622,332 63,578,121 The computation of diluted EPS for the three and nine months ended September 30, 2019 and 2018 excludes the following potentially dilutive securities because their inclusion would be anti-dilutive: Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 Unvested restricted stock 38,585 328,353 506,035 995,568 Performance based restricted stock — 31,162 — 49,202 Total 38,585 359,515 506,035 1,044,770 The weighted-average common shares outstanding used to calculate diluted EPS from discontinued operations for the three and nine months ended September 30, 2018 is 64,270,995 and 64,622,891, respectively.
Concentration of Credit Risk	Concentration of Credit Risk Financial instruments which potentially expose the Company to credit risk consist primarily of cash, restricted cash and accounts receivable. Cash is held to meet working capital needs and future acquisitions. Restricted cash is pledged as collateral for a comparable amount of irrevocable standby letters of credit for certain of the Company’s leased properties. Substantially all of the Company’s cash and restricted cash are deposited with high quality financial institutions. At times, however, such cash and restricted cash may be in deposit accounts that exceed the Federal Deposit Insurance Corporation insurance limit. The Company has not experienced any losses in such accounts as of September 30, 2019. Concentration of credit risk with respect to accounts receivable is minimal due to the collection history. The Company performs periodic credit evaluations of its customers’ financial condition. The allowance for doubtful accounts is based upon the expected collectability of all accounts receivable.
Customer Concentrations	Customer Concentrations The Company recorded net revenues from continuing operations of $25.4 million and $29.5 million during the three months ended September 30, 2019 and 2018, respectively. During the three months ended September 30, 2019, three licensees represented at least 10% of net revenue from continuing operations, accounting for 17%, 17% and 16% of the Company’s net revenue from continuing operations. During the three months ended September 30, 2018, three licensees represented at least 10% of net revenue from continuing operations, accounting for 21%, 14% and 11% of the Company’s net revenue from continuing operations. The Company recorded net revenues from continuing operations of $77.3 million and $92.0 million during the nine months ended September 30, 2019 and 2018, respectively. During the nine months ended September 30, 2019, three licensees represented at least 10% of net revenue from continuing operations, accounting for 19%, 16% and 14% of the Company’s net revenue from continuing operations. During the nine months ended September 30, 2018, two licensees represented at least 10% of net revenue from continuing operations, accounting for 18% and 13% of the Company’s net revenue from continuing operations.
Loss Contingencies	Loss Contingencies The Company recognizes contingent losses that are both probable and estimable. In this context, probable means circumstances under which events are likely to occur. The Company records legal costs pertaining to contingencies as incurred.
Noncontrolling Interest	Noncontrolling Interest Noncontrolling interest recorded for the three and nine months ended September 30, 2019 in continuing operations represents income allocations to Elan Polo International, Inc., a member of DVS Footwear International, LLC and With You, Inc., a member of With You LLC (the partnership between the Company and Jessica Simpson).
Discontinued Operations	Discontinued Operations The Company accounted for the sale of MSLO in accordance with ASC 360, Accounting for Impairment or Disposal of Long-Lived Assets (“ASC 360”) and Accounting Standard Update No. 2014-08, Reporting of Discontinued Operations and Disclosures of Disposals of Components of an Entity (“ASU 2014-08”). The Company followed the held-for-sale criteria as defined in ASC 360. ASC 360 requires that a component of an entity that has been disposed of or is classified as held for sale and has operations and cash flows that can be clearly distinguished from the rest of the entity be reported as assets held for sale and discontinued operations. In the period a component of an entity has been disposed of or classified as held for sale, the results of operations for the periods presented are reclassified into separate line items in the statements of operations. Assets and liabilities are also reclassified into separate line items on the related balance sheets for the periods presented. The statements of cash flows for the periods presented are also reclassified to reflect the results of discontinued operations as separate line items. ASU 2014-08 requires that only a disposal of a component of an entity, or a group of components of an entity, that represents a strategic shift that has, or will have, a major effect on the reporting entity’s operations and financial results be reported in the financial statements as discontinued operations. ASU 2014-08 also provides guidance on the financial statement presentations and disclosures of discontinued operations.
Reportable Segment	Reportable Segment An operating segment, in part, is a component of an enterprise whose operating results are regularly reviewed by the chief operating decision maker (the “CODM”) to make decisions about resources to be allocated to the segment and assess its performance. Operating segments may be aggregated only to a limited extent. The Company’s CODM, the President, reviews financial information presented on a consolidated basis, accompanied by disaggregated information about revenues for purposes of making operating decisions and assessing financial performance. Accordingly, the Company has determined that it has a single operating and reportable segment. In addition, the Company has no foreign offices or any assets in foreign locations. The majority of the Company’s operations consist of a single revenue stream, which is the licensing of its trademark portfolio, with additional revenues derived from television, book, and certain commissions.
New Accounting Pronouncements	New Accounting Pronouncements ASU No. 2018-18, “Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606” In November 2018, the FASB issued ASU No. 2018-18 “ Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606 ” (“ASU 2018-18”). ASU 2018-18 amends ASC 808, Collaborative Arrangements (“ ASC 808”) and ASC 606, Revenue from Contracts with Customers (“ASC 606”) to clarify that certain transactions between participants in a collaborative arrangement should be accounted for under ASC 606 when the counterparty is a customer. ASU 2018-18 is effective for annual and interim periods beginning after December 15, 2019, and early adoption is permitted. The Company does not expect the adoption of ASU 2018-18 to have a material impact on the Company’s consolidated financial statements. ASU No. 2018-15, “ Intangibles—Goodwill and Other— Internal-Use Software (Subtopic 350-40) Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract” In August 2018, the FASB issued ASU No. 2018-15, “ Intangibles—Goodwill and Other— Internal-Use Software (Subtopic 350-40) Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract” (“ASU 2018-15”). Under ASU 2018-15 customers will apply the same criteria used for capitalizing implementation costs incurred for an internal-use software license to implementation costs incurred in a cloud computing arrangement. ASU 2018-15 is effective for annual and interim periods beginning after December 15, 2019, and early adoption is permitted. The Company does not expect the adoption of ASU 2018-15 to have a material impact on the Company condensed consolidated financial statements. ASU No. 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement” In August 2018, the FASB issued ASU No. 2018-13 “ Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement ” (“ASU 2018-13”). ASU 2018-13 eliminates, amends, and adds certain disclosure requirements for fair value measurements. ASU 2018-13 is effective for annual and interim periods beginning after December 15, 2019, and early adoption is permitted for the entire standard or for the provisions that eliminate or amend disclosure requirements. The Company does not expect the adoption of ASU 2018-13 to have a material impact on the Company’s condensed consolidated financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2019
Summary of Significant Accounting Policies [Abstract]
Shares Used to Calculate Basic And Diluted Earnings (Loss) Per Common Share	Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 Basic weighted-average common shares outstanding 64,952,093 63,911,481 64,622,332 63,578,121 Performance based restricted stock — — — — Unvested restricted stock — — — — Diluted weighted-average common shares outstanding 64,952,093 63,911,481 64,622,332 63,578,121
Earnings Per Share, Basic and Diluted	Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 Unvested restricted stock 38,585 328,353 506,035 995,568 Performance based restricted stock — 31,162 — 49,202 Total 38,585 359,515 506,035 1,044,770

Discontinued Operations (Tables

Discontinued Operations (Tables)	9 Months Ended
	Sep. 30, 2019
Discontinued Operations
Schedule of discontinued operations unaudited condensed consolidated statements of operations	Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 (in thousands) Net revenue $ - $ 11,315 $ 18,771 $ 29,037 Operating expenses 114 8,100 16,503 18,033 Impairment charges - - 161,224 - Loss on sale of MSLO - - 2,008 - (Loss) income from operations (114) 3,215 (160,964) 11,004 Other expense 136 - 236 - Interest expense - 1,773 3,570 5,066 (Loss) income from discontinued operations before income taxes (250) 1,442 (164,770) 5,938 Provision for (benefit from) income taxes 59 595 (42,578) 2,451 (Loss) income from discontinued operations $ (309) $ 847 $ (122,192) $ 3,487
Schedule of discontinued operations balance sheet	September 30, December 31, 2019 2018 (in thousands) Carrying amount of assets included as part of discontinued operations: Current Assets: Accounts receivable, net $ - $ 16,602 Prepaid expenses and other current assets 9,218 7,243 Total current assets classified as held for disposition from discontinued operations 9,218 23,845 Property and equipment, net - 580 Intangible assets, net - 330,084 Total assets classified as held for disposition from discontinued operations $ 9,218 $ 354,509 Carrying amount of liabilities included as part of discontinued operations: Current Liabilities: Accounts payable and accrued expenses $ 3,731 $ 11,927 Current portion of deferred revenue - 3,523 Total current liabilities classified as held for disposition from discontinued operations 3,731 15,450 Deferred income taxes - 34,938 Other long-term liabilities - 3,629 Total liabilities classified as held for disposition from discontinued operations $ 3,731 $ 54,017
Schedule of discontinued operations cash flow	Nine Months Ended September 30, 2019 2018 (in thousands) Cash provided by discontinued operating activities $ 7,647 $ 4,711 Cash used in discontinued investing activities $ (44) $ (44) Cash used in discontinued financing activities $ (574) $ (975)

Fair Value Measurement of Fin_2

Fair Value Measurement of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2019
Fair Value Measurement of Financial Instruments [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis	Carrying Value Fair Value Financial Instrument Level 9/30/2019 12/31/2018 9/30/2019 12/31/2018 (in thousands) Equity securities 1 $ 542 $ 627 $ 542 $ 627 Interest rate swaps - liability 2 $ 7,474 $ 2,019 $ 7,474 $ 2,019 Term loans 2 $ 456,331 $ 519,850 $ 453,497 $ 515,742 Revolving loan 2 $ 5,358 $ 115,000 $ 5,357 $ 114,827
Schedule of Notional Amounts of Outstanding Derivative Positions	Notional Value Derivative Asset Derivative Liability (in thousands) LIBOR based loans $ 300,000 $ — $ 7,474

Revenues (Tables)

Revenues (Tables)	9 Months Ended
	Sep. 30, 2019
Revenues [Abstract]
Disaggregated Revenue	The following table presents revenue from continuing operations disaggregated by source: Three Months Ended September 30, Nine Months Ended September 30, 2019 2018 2019 2018 (in thousands) Licensing agreements $ 25,084 $ 26,836 $ 76,859 $ 85,413 Other 308 2,619 472 6,631 Total $ 25,392 $ 29,455 $ 77,331 $ 92,044
Contract Balances	The below table summarizes the Company’s contract assets and contract liabilities: September 30, December 31, 2019 2018 (in thousands) Contract assets $ 2,177 $ 2,484 Contract liabilities 3,403 4,923
Future Performance Obligations	The below table summarizes amounts related to future performance obligations from continuing operations under fixed contractual arrangements as of September 30, 2019 and the periods in which they are expected to be earned and recognized as revenue: 2019 2020 2021 2022 2023 Thereafter (in thousands) Future Performance Obligations $ 14,514 $ 40,576 $ 26,107 $ 5,929 $ 4,555 $ 244

Leases (Tables)

Leases (Tables)	9 Months Ended
	Sep. 30, 2019
Lease
Summary of operating lease assets and liabilities recorded on the balance sheet	September 30, Classification on Balance Sheet 2019 Assets (in thousands) Non-current Right-of-use assets - operating leases $ 48,237 Liabilities Current Current portion of lease liabilities - operating leases $ 2,869 Non-current Lease liabilities - operating leases 52,285 Total operating lease liabilities $ 55,154 Weighted average remaining lease term (in years) 13.6
Summary of maturities of the Company’s lease liabilities	As of September 30, 2019, the maturities of the Company’s lease liabilities were as follows: Operating Leases (in thousands) 2019 (remaining three months) $ 1,632 2020 6,450 2021 6,295 2022 6,295 2023 6,277 Thereafter 58,320 Total minimum lease payments 85,269 Less: imputed interest 30,115 Lease liabilities $ 55,154

Intangible Assets (Tables)

Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2019
Intangible Assets [Abstract]
Summary of Intangible Assets	Gross Useful Lives Carrying Accumulated Net Carrying September 30, 2019 (Years) Amount Amortization Amount (in thousands) Finite-lived intangible assets: Trademarks 5 - 15 $ 12,480 $ (4,056) $ 8,424 Customer agreements 4 2,200 (2,196) 4 Patents 10 95 (62) 33 $ 14,775 $ (6,314) 8,461 Indefinite-lived intangible assets: Trademarks 591,933 Intangible assets, net $ 600,394 Gross Useful Lives Carrying Accumulated Net Carrying December 31, 2018 (Years) Amount Amortization Amount (in thousands) Finite-lived intangible assets: Trademarks 5 - 15 $ 12,438 $ (2,689) $ 9,749 Customer agreements 4 2,200 (2,147) 53 Patents 10 361 (321) 40 $ 14,999 $ (5,157) 9,842 Indefinite-lived intangible assets: Trademarks 624,985 Intangible assets, net $ 634,827
Summary of Future Annual Estimated Amortization Expense	Estimated future annual amortization expense for intangible assets in service as of September 30, 2019 is summarized as follows: Years Ended December 31, (in thousands) Remainder of 2019 $ 462 2020 1,838 2021 1,835 2022 1,812 2023 1,387 Thereafter 1,127 $ 8,461

Long-Term Debt (Tables)

Long-Term Debt (Tables)	9 Months Ended
	Sep. 30, 2019
Long-Term Debt [Abstract]
Schedule of Long Term Debt	The components of long-term debt are as follows: September 30, December 31, 2019 2018 (in thousands) Secured Term Loans $ 456,331 $ 519,850 Revolving Credit Facility 5,358 115,000 Unamortized deferred financing costs (22,608) (24,063) Total long-term debt, net of unamortized deferred financing costs 439,081 610,787 Less: current portion of long-term debt 21,000 28,300 Long-term debt $ 418,081 $ 582,487

Stock-based Compensation (Table

Stock-based Compensation (Tables)	9 Months Ended
	Sep. 30, 2019
Stock-based Compensation
Summary of Stock Option Activity	The following table summarizes the Company’s stock option activity for the nine months ended September 30, 2019: Weighted-Average Remaining Number of Weighted-Average Contractual Life Aggregate Options Exercise Price (in Years) Intrinsic Value (in thousands, except share and per share data) Outstanding - January 1, 2019 49,501 $ 10.22 2.3 $ — Granted — — Exercised — — Forfeited or canceled (10,000) (13.68) Outstanding at September 30, 2019 39,501 $ 9.34 2.0 $ — Exercisable - September 30, 2019 39,501 $ 9.34 2.0 $ —
Schedule of Warrants Activity and Nonvested Warrants	The following table summarizes the Company’s outstanding warrants for the nine months ended September 30, 2019: Weighted-Average Remaining Number of Weighted-Average Contractual Life Aggregate Warrants Exercise Price (in Years) Intrinsic Value (in thousands, except share and per share data) Outstanding - January 1, 2019 200,000 $ 13.32 6.4 $ — Granted — — Exercised — — Forfeited or canceled — — Outstanding at September 30, 2019 200,000 $ 13.32 5.7 $ — Exercisable - September 30, 2019 200,000 $ 13.32 5.7 $ —
Schedule of Restricted Stock Activity	A summary of the Company’s time-based restricted stock activity for the nine months ended September 30, 2019 is as follows: Weighted-Average Weighted-Average Remaining Grant Date Fair Contractual Life Number of Shares Value (in Years) Unvested - January 1, 2019 292,989 $ 3.72 0.9 Granted 464,576 0.86 Vested (235,296) (1.70) Unvested - September 30, 2019 522,269 $ 0.85 0.8
Schedule of Restricted Stock Units Activity	A summary of the Company’s time-based restricted stock units activity for the nine months ended September 30, 2019 is as follows: Weighted-Average Weighted-Average Remaining Grant Date Fair Contractual Life Number of Shares Value (in Years) Unvested - January 1, 2019 1,615,953 $ 2.24 2.2 Granted — — Vested (574,582) (2.85) Forfeited or canceled (40,000) (1.76) Unvested - September 30, 2019 1,001,371 $ 1.25 1.3
Schedule of Performance Stock Units Activity	A summary of the Company’s PSUs activity for the nine months ended September 30, 2019 is as follows: 0 Weighted-Average Weighted-Average Remaining Grant Date Fair Contractual Life Number of Shares Value (in Years) Unvested - January 1, 2019 2,219,818 $ 4.47 0.8 Granted — — Vested (289,671) (4.68) Forfeited or canceled (511,491) (6.59) Unvested - September 30, 2019 1,418,656 $ 3.66 0.9

Organization and Nature of Op_2

Organization and Nature of Operations (Details)	Sep. 30, 2019entity
Minimum [Member]
Number of licensees	100

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Narrative) (Details)	Jun. 10, 2019USD ($)	Sep. 30, 2019USD ($)shares	Mar. 31, 2019USD ($)	Sep. 30, 2018USD ($)shares	Sep. 30, 2019USD ($)segmententityshares	Sep. 30, 2018USD ($)shares	Dec. 31, 2018USD ($)	Jul. 01, 2016
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Net revenue		$ 25,392,000		$ 29,455,000	$ 77,331,000	$ 92,044,000
Revenue from Contract with Customer, Including Assessed Tax		25,392,000		29,455,000	77,331,000	92,044,000
Allowance for doubtful accounts receivable		1,900,000			1,900,000		$ 1,800,000
Accounts receivable, net		41,409,000			41,409,000		$ 49,600,000
Decrease in accounts receivable					16,600,000
Loss on equity securities		400,000		0	85,000	0
(Loss) income from discontinued operations, net of tax		$ (309,000)		$ 847,000	(122,192,000)	3,487,000
Increase (decrease) in intangible assets					(330,100,000)
Impairment of trademark					$ 33,109,000	$ 17,899,000
Number of operating segments | segment					1
Number of reportable segments | segment					1
Diluted weighted-average common shares outstanding | shares		64,952,093		63,911,481	64,622,332	63,578,121
Discontinued Operations [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Diluted weighted-average common shares outstanding | shares				64,270,995		64,622,891
Minimum [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Useful Lives					2 years
Maximum
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Useful Lives					15 years
Trademarks [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Impairment of trademark		$ 33,100,000	$ 161,200,000	$ 17,900,000
Number of indefinite-lived intangible assets | entity					2
Jessica Simpson Trademark [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Impairment of trademark		28,500,000
Joe’s Trademark [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Impairment of trademark		$ 4,600,000
Gaiam Pty Limited [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Equity method investment, noncontrolling interest								49.90%
Accounts Receivable [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Concentration risk, percentage					49.00%		41.00%
Accounts Receivable [Member] | License One [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Concentration risk, percentage					32.00%		25.00%
Accounts Receivable [Member] | License Two [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Concentration risk, percentage					17.00%		16.00%
Sales Revenue, Services, Net [Member] | License One [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Concentration risk, percentage		17.00%		21.00%	19.00%	18.00%
Sales Revenue, Services, Net [Member] | License Two [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Concentration risk, percentage		17.00%		14.00%	16.00%	13.00%
Sales Revenue, Services, Net [Member] | License Three [Member]
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Concentration risk, percentage		16.00%		11.00%	14.00%
Sale | MSLO
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Cash consideration	$ 166,000,000
Earnout on performance target achieved during first three year	$ 40,000,000
(Loss) income from discontinued operations, net of tax		$ (309,000)	$ 161,200,000	$ 847,000	$ (122,192,000)	$ 3,487,000
Intangible assets, net							$ 330,084,000

Summary of Significant Accoun_5

Summary of Significant Accounting Policies (Basic and Diluted Weighted Average Common Shares Outstanding) (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Earnings Per Share [Abstract]
Basic weighted-average common shares outstanding	64,952,093	63,911,481	64,622,332	63,578,121
Diluted weighted-average common shares outstanding	64,952,093	63,911,481	64,622,332	63,578,121

Summary of Significant Accoun_6

Summary of Significant Accounting Policies (Antidilutive Shares Excluded from Computation of Diluted EPS) (Details) - shares	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	38,585	359,515	506,035	1,044,770
Performance based restricted stock
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share		31,162		49,202
Unvested restricted stock
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share	38,585	328,353	506,035	995,568

Discontinued Operations (Narrat

Discontinued Operations (Narrative) (Details) - USD ($)	Jun. 10, 2019	Sep. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Discontinued Operations
(Loss) income from discontinued operations, net of tax		$ (309,000)		$ 847,000	$ (122,192,000)	$ 3,487,000
Interest expense		0
Revolving Credit Facility [Member]
Discontinued Operations
Mandatory prepayment	$ 109,600,000
Tranche A -1 Term Loans [Member]
Discontinued Operations
Voluntary prepayment	44,400,000
Sale | MSLO
Discontinued Operations
Cash consideration	166,000,000
Earnout on performance target achieved during first three year	$ 40,000,000
Pre-tax loss					(2,008,000)
Non-cash impairment charges			$ 161,200,000		161,224,000
(Loss) income from discontinued operations, net of tax		(309,000)	$ 161,200,000	847,000	(122,192,000)	3,487,000
Interest expense				$ 1,773,000	3,570,000	$ 5,066,000
Transaction costs					$ 6,000,000
Sale | MSLO | Maximum
Discontinued Operations
Transaction costs		$ 100,000

Discontinued Operations - State

Discontinued Operations - Statement of operations (Details) - USD ($) $ in Thousands	3 Months Ended			9 Months Ended
	Sep. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Discontinued operations unaudited condensed consolidated statement of operations
Interest expense	$ 0
(Loss) income from discontinued operations	(309)		$ 847	$ (122,192)	$ 3,487
Sale | MSLO
Discontinued operations unaudited condensed consolidated statement of operations
Net revenue			11,315	18,771	29,037
Operating expenses	114		8,100	16,503	18,033
Impairment charges		$ 161,200		161,224
Loss on sale of MSLO				2,008
(Loss) income from operations	(114)		3,215	(160,964)	11,004
Other expense	136			236
Interest expense			1,773	3,570	5,066
(Loss) income from discontinued operations before income taxes	(250)		1,442	(164,770)	5,938
(Benefit from) provision for income taxes	59		595	(42,578)	2,451
(Loss) income from discontinued operations	$ (309)	$ 161,200	$ 847	$ (122,192)	$ 3,487

Discontinued Operations - Balan

Discontinued Operations - Balance Sheets (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Current Assets:
Total current assets classified as held for disposition from discontinued operations	$ 9,218	$ 23,845
Current Liabilities:
Disposal Group, Including Discontinued Operation, Liabilities, Current, Total	3,731	15,450
Sale | MSLO
Current Assets:
Accounts receivable, net		16,602
Prepaid expenses and other current assets	9,218	7,243
Total current assets classified as held for disposition from discontinued operations	9,218	23,845
Property and equipment, net		580
Intangible assets, net		330,084
Total assets classified as held for disposition from discontinued operations	9,218	354,509
Current Liabilities:
Accounts payable and accrued expenses	3,731	11,927
Current portion of deferred revenue		3,523
Disposal Group, Including Discontinued Operation, Liabilities, Current, Total	3,731	15,450
Deferred income taxes		34,938
Other long-term liabilities		3,629
Total liabilities classified as held for disposition from discontinued operations	$ 3,731	$ 54,017

Discontinued Operations - Cash

Discontinued Operations - Cash Flows (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash provided by discontinued operating activities	$ 7,647	$ 4,711
Cash used in discontinued investing activities	(44)	(44)
Cash used in discontinued financing activities	(574)	(975)
Sale | MSLO
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Cash provided by discontinued operating activities	7,647	4,711
Cash used in discontinued investing activities	(44)	(44)
Cash used in discontinued financing activities	$ (574)	$ (975)

Fair Value Measurement of Fin_3

Fair Value Measurement of Financial Instruments (Narrative) (Details) $ in Thousands	Jun. 10, 2019USD ($)	Sep. 30, 2019USD ($)	Mar. 31, 2019USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2019USD ($)entity	Sep. 30, 2018USD ($)
Increase (Decrease) in Intangible Assets, Current					$ (330,100)
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest		$ (309)		$ 847	(122,192)	$ 3,487
Impairment of trademark					33,109	17,899
Loss on Cash Flow Hedge Ineffectiveness					400
Loss from Components Excluded from Assessment of Cash Flow Hedge Effectiveness		400			$ 900
Gross licensing revenue payable, percentage					3.50%
Licensing revenue payment period					5 years
Fair Value Of Legacy Payments Increase (Decrease)	$ (2,600)
Amortization expense		500		200	$ 1,400	$ 500
Trademarks [Member]
Impairment of trademark		$ 33,100	$ 161,200	$ 17,900
Number of indefinite-lived intangible assets | entity					2
Amortization expense					$ 0
Interest Rate Cap [Member]
Derivative Notional Amounts					$ 300,000

Fair Value Measurement of Fin_4

Fair Value Measurement of Financial Instruments (Schedule of Indefinite-lived Assets) (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended			9 Months Ended
	Jun. 30, 2019	Sep. 30, 2019	Mar. 31, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Indefinite-lived Intangible Assets [Line Items]
Impairment charges					$ (33,109)	$ (17,899)
Reclassified to finite-lived intangible assets	$ (330,100)
Trademarks [Member]
Indefinite-lived Intangible Assets [Line Items]
Balance at January 1			$ 624,985		624,985
Impairment charges		$ (33,100)	$ (161,200)	$ (17,900)
Balance at March 31		$ 591,933			$ 591,933

Fair Value Measurement of Fin_5

Fair Value Measurement of Financial Instruments (Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis) (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Fair Value, Inputs, Level 1 [Member] | Equity Securities [Member] | Carrying Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	$ 542	$ 627
Fair Value, Inputs, Level 1 [Member] | Equity Securities [Member] | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Term loan	542	627
Fair Value, Inputs, Level 2 [Member] | Interest Rate Swap [Member] | Carrying Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	7,474	2,019
Fair Value, Inputs, Level 2 [Member] | Interest Rate Swap [Member] | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Term loan	7,474	2,019
Fair Value, Inputs, Level 2 [Member] | Fair Value, Measurements, Nonrecurring [Member] | Term Loans Member | Carrying Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Term loan	456,331	519,850
Fair Value, Inputs, Level 2 [Member] | Fair Value, Measurements, Nonrecurring [Member] | Term Loans Member | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Term loan	453,497	515,742
Fair Value, Inputs, Level 2 [Member] | Fair Value, Measurements, Nonrecurring [Member] | Revolving Loans [Member] | Carrying Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liability	5,358	115,000
Fair Value, Inputs, Level 2 [Member] | Fair Value, Measurements, Nonrecurring [Member] | Revolving Loans [Member] | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Term loan	$ 5,357	$ 114,827

Fair Value Measurement of Fin_6

Fair Value Measurement of Financial Instruments (Schedule of Notional Amounts of Outstanding Derivative Positions) (Details) - USD ($) $ in Thousands	Dec. 10, 2018	Sep. 30, 2019	Dec. 31, 2018
Interest Rate Swap [Member]
Derivatives, Fair Value [Line Items]
Notional Value	$ 300,000		$ 300,000
Interest Rate Cap [Member]
Derivatives, Fair Value [Line Items]
Notional Value		$ 300,000
Derivative Liability		$ 7,474

Revenues (Narrative) (Details)

Revenues (Narrative) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Revenues [Abstract]
Retained Earnings (Accumulated Deficit), Total	$ (383,347)		$ (383,347)		$ (234,723)
Accounts receivable, net	41,409		41,409		49,600
Noncontrolling interest	60,068		60,068		70,726
Deferred income taxes	15,438		15,438		$ 32,064
Net revenue	25,392	$ 29,455	77,331	$ 92,044
Benefit for income taxes	$ (6,035)	$ (8,808)	$ (6,655)	$ (9,289)

Revenues (Disaggregated Revenue

Revenues (Disaggregated Revenue) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Disaggregated revenue	$ 25,392	$ 29,455	$ 77,331	$ 92,044
Licensing Agreements [Member]
Disaggregated revenue	25,084	26,836	76,859	85,413
Other Contract [Member]
Disaggregated revenue	$ 308	$ 2,619	$ 472	$ 6,631

Revenues (Contract Balances) (D

Revenues (Contract Balances) (Details) - USD ($) $ in Thousands	Jun. 10, 2019	Sep. 30, 2019	Dec. 31, 2018
Revenues [Abstract]
Contract assets		$ 2,177	$ 2,484
Contract liabilities		$ 3,403	$ 4,923
decrease in contract assets	$ 700
decrease in contract liabilities	$ 100

Revenues (Future Performance Ob

Revenues (Future Performance Obligations) (Details) $ in Thousands	Sep. 30, 2019USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Future Performance Obligations	$ 14,514
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Future Performance Obligations	40,576
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Future Performance Obligations	26,107
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Future Performance Obligations	5,929
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Future Performance Obligations	4,555
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Future Performance Obligations	$ 244

Revenues (Future Performance _2

Revenues (Future Performance Obligations Alternate) (Details)	Sep. 30, 2019
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	3 months
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-01-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period	0 years

Leases - (Details)

Leases - (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Lease
Discount rate for the leases	6.76%		6.76%
Rent expense for operating leases	$ 1.5	$ 1.5	$ 4.6
Rent expense for operating leases				$ 4.5
Sublease income	$ 0.4	$ 0.1	$ 0.8	$ 0.5
Lease, Practical Expedients, Package			true

Leases - Lease Assets and Liabi

Leases - Lease Assets and Liabilities (Details) $ in Thousands	Sep. 30, 2019USD ($)
Operating lease assets and liabilities recorded on the balance sheet
Right-of-use assets - operating leases	$ 48,237
Financial position	us-gaap:OtherAssetsNoncurrent
Current portion of lease liabilities - operating leases	$ 2,869
Financial position	us-gaap:OtherLiabilitiesCurrent
Lease liabilities - operating leases	$ 52,285
Financial position	us-gaap:OtherLiabilitiesNoncurrent
Total operating lease liabilities	$ 55,154
Weighted average remaining lease term (in years)	13 years 7 months 6 days

Leases - Maturities of Lease Li

Leases - Maturities of Lease Liabilities (Details) $ in Thousands	Sep. 30, 2019USD ($)
Maturities of the Company’s lease liabilities
2019 (remaining three months)	$ 1,632
2020	6,450
2021	6,295
2022	6,295
2023	6,277
Thereafter	58,320
Total minimum lease payments	85,269
Less: imputed interest	30,115
Lease liabilities	$ 55,154

Intangible Assets (Narrative) (

Intangible Assets (Narrative) (Details) $ in Thousands	1 Months Ended	3 Months Ended			9 Months Ended
	Jun. 30, 2019USD ($)	Sep. 30, 2019USD ($)	Mar. 31, 2019USD ($)	Sep. 30, 2018USD ($)	Sep. 30, 2019USD ($)entity	Sep. 30, 2018USD ($)
Amortization expense		$ 500		$ 200	$ 1,400	$ 500
Loss on sale of assets						(7,117)
Impairment charges		33,109		17,899	33,109	17,899
Indefinite-lived intangible assets, period increase (decrease)	$ (330,100)
Impairment of trademark					33,109	$ 17,899
Trademarks [Member]
Amortization expense					$ 0
Impairment of trademark		33,100	$ 161,200	$ 17,900
Number of indefinite-lived intangible assets | entity					2
Jessica Simpson Trademark [Member]
Impairment of trademark		28,500
Joe’s Trademark [Member]
Impairment of trademark		$ 4,600

Intangible Assets (Summary of I

Intangible Assets (Summary of Intangible Assets) (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Schedule Of Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 14,775	$ 14,999
Accumulated Amortization	(6,314)	(5,157)
Finite-lived intangible assets, net	8,461	9,842
Net Carrying Amount, Intangible Assets	$ 600,394	634,827
Minimum [Member]
Schedule Of Finite Lived Intangible Assets [Line Items]
Useful Lives	2 years
Maximum
Schedule Of Finite Lived Intangible Assets [Line Items]
Useful Lives	15 years
Trademarks [Member]
Schedule Of Finite Lived Intangible Assets [Line Items]
Indefinite lived intangible assets	$ 591,933	624,985
Trademarks [Member]
Schedule Of Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	12,480	12,438
Accumulated Amortization	(4,056)	(2,689)
Finite-lived intangible assets, net	$ 8,424	$ 9,749
Trademarks [Member] | Minimum [Member]
Schedule Of Finite Lived Intangible Assets [Line Items]
Useful Lives	5 years	5 years
Trademarks [Member] | Maximum
Schedule Of Finite Lived Intangible Assets [Line Items]
Useful Lives	15 years	15 years
Customer Contracts [Member]
Schedule Of Finite Lived Intangible Assets [Line Items]
Useful Lives	4 years	4 years
Gross Carrying Amount	$ 2,200	$ 2,200
Accumulated Amortization	(2,196)	(2,147)
Finite-lived intangible assets, net	$ 4	$ 53
Patents [Member]
Schedule Of Finite Lived Intangible Assets [Line Items]
Useful Lives	10 years	10 years
Gross Carrying Amount	$ 95	$ 361
Accumulated Amortization	(62)	(321)
Finite-lived intangible assets, net	$ 33	$ 40

Intangible Assets (Future Annua

Intangible Assets (Future Annual Estimated Amortization Expense) (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018
Intangible Assets [Abstract]
Remainder of 2019	$ 462
2020	1,838
2021	1,835
2022	1,812
2023	1,387
Thereafter	1,127
Intangible assets amortization, total	8,461	$ 9,842
Intangible Assets, Net (Excluding Goodwill), Total	$ 600,394	$ 634,827

Intangible Assets (Changes in I

Intangible Assets (Changes in Indefinite-Lived Intangible Assets) (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018
Intangible Assets [Abstract]
Impairment charges			$ (33,109)	$ (17,899)
Amortization	$ 500	$ 200	$ 1,400	$ 500

Long-Term Debt (Narrative) (Det

Long-Term Debt (Narrative) (Details) - USD ($)	Aug. 12, 2019	Jun. 10, 2019	Dec. 10, 2018	Aug. 07, 2018	Jul. 02, 2016	Sep. 30, 2019	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018	Jul. 01, 2016
Disclosure Long Term Debt Additional Information [Line Items]
Proceeds from issuance of long-term debt								$ 107,607,000
Long-term debt						$ 439,081,000	$ 439,081,000		$ 610,787,000
Line of credit facility, current borrowing capacity						24,400,000	24,400,000
Interest Rate Cap [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Derivative Notional Amounts							300,000,000
Interest Rate Swap [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Derivative Notional Amounts			$ 300,000,000						$ 300,000,000
Derivative, maturing in 2021							150,000,000
Derivative, maturing in 2022							150,000,000
Derivative loss						400,000	900,000
Other comprehensive income (loss) reclassification due to de-designation							$ 400,000
Revolving Credit Facility [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Repayments of debt		$ 109,600,000
BoA Credit Agreement [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument period of credit agreement				5 years
Proceeds from issuance of long-term debt					$ 335,000,000
Debt instrument covenant payment percentage of intellectual property disposed liquidation value							50.00%
Debt instrument covenant payment percentage of net proceeds related to other assets constituting collateral							100.00%
Debt instrument orderly liquidation value of registered trademarks percentage benchmark							15.00%
Debt instrument, covenant description							(i) maintain a positive net income, (ii) satisfy a maximum loan to value ratio initially set at 50.0% (applicable to the Amended Revolving Loans and Amended Tranche A Loans) decreasing over the term of the Amended BoA Credit Agreement until reaching a final maximum loan to value ratio of 42.5% and (iii) satisfy a maximum consolidated first lien leverage ratio, initially set at 3.875:1:00, decreasing over the term of the Amended BoA Credit Agreement until reaching a final maximum ratio of 2.875:1.00 for the fiscal quarter ending September 30, 2022 and thereafter.
Debt instrument, description							(i) the loans outstanding under the Amended BoA Credit Agreement plus, (a) where intellectual property is disposed, 50.0% of the disposed intellectual property's orderly liquidation value, and (b) where any other assets constituting collateral are disposed or upon the receipt of certain insurance proceeds, 100% of the net proceeds thereof, subject to certain reinvestment rights; and (ii) the Amended Tranche A-1 Loans to the extent that the outstanding principal amount thereof exceeds 15.0% of the orderly liquidation value of the registered trademarks owned by the BoA Facility Loan Parties.
Debt instrument, covenant compliance							At September 30, 2019, the Company is in compliance with the covenants included in the Amended BoA Credit Agreement.
BoA Term Loans [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument, periodic payment							$ 5,000,000
Debt instrument, date of first required payment							Sep. 30, 2016
Tranche A [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Maximum loan to value ratio							50.00%
Tranche A [Member] | Revolving Credit Facility [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Consolidated first lien leverage ratio							2.80%
Line of credit facility, covenant terms							(i) the Revolving Credit Facility and Tranche A Loans as would not cause the consolidated first lien leverage ratio, determined on a pro forma basis after giving effect to any such increase, to exceed 2.80:1.00 and (ii) the Tranche A-1 Loans, as would not cause the consolidated first lien leverage ratio, determined on a pro forma basis after giving effect to any such increase, to exceed (a) with respect to any increase, the proceeds of which will be used solely to finance an acquisition, 3.00:1.00 and (b) with respect to any other increase, 2.90:1.00, subject to the satisfaction of certain conditions in the Amended BoA Credit Agreement.
Tranche A -1 Term Loans [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Deferred financing costs							$ 600,000
Repayments of debt		$ 44,400,000
Revolving Loans [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Long-term debt										$ 115,000,000
Maximum loan to value ratio							50.00%
Revolving Loans [Member] | Notes Payable to Banks [Member] | London Interbank Offered Rate (LIBOR) [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument, basis spread on variable rate							3.50%
GSO Credit Agreement [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument, covenant description							(a) in the event the consolidated total leverage ratio was at least 4.00:1.00, 75% thereof, (b) in the event the consolidated total leverage ratio was less than 4.00:1.00 but at least 3.00:1.00, 50% thereof and (c) in the event the consolidated total leverage ratio was less than 3.00:1.00, 0% thereof.
Line of credit facility, interest rate description							(i) the LIBOR rate plus 8.75% per annum or (ii) the base rate plus 7.75% per annum.
Debt instrument, covenant compliance							At September 30, 2019, the Company is in compliance with the covenants included in the Amended FS/KKR Credit Agreement.
GSO Credit Agreement Reinvestment Rights Scenario Three [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument covenant payment percentage of net proceeds related to other assets constituting collateral							0.00%
Amended KKR Credit Agreement [Member] | Scenario Plan One [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument covenant payment percentage of net proceeds related to other assets constituting collateral							75.00%
Amended KKR Credit Agreement [Member] | Scenario Plan Two [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument covenant payment percentage of net proceeds related to other assets constituting collateral							50.00%
Amended FS/KKR Credit Agreement [Member] | August 2018 Debt Facilities Member
Disclosure Long Term Debt Additional Information [Line Items]
Quarterly amortization payments	$ 1,000,000
Netting of cash for calculating leverage ratio covenant	5,000,000
Amended FS/KKR Credit Agreement [Member] | Revolving Credit Facility [Member] | August 2018 Debt Facilities Member
Disclosure Long Term Debt Additional Information [Line Items]
Line of credit facility, maximum borrowing capacity	30,000,000
Deferred financing costs						$ 3,300,000
FS/KKR Credit Agreement [Member] | London Interbank Offered Rate (LIBOR) [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument, basis spread on variable rate							8.75%
FS/KKR Credit Agreement [Member] | Base Rate [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument, basis spread on variable rate							7.75%
FS/KKR Credit Agreement [Member] | Senior secured term loan facility
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument, face amount										314,000,000
Debt instrument consolidated total leverage ratio							6.00%
New Amended FS/KKR Credit Agreement [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Quarterly amortization payments	$ 1,000,000
Debt instrument covenant payment percentage of intellectual property disposed liquidation value					50.00%
Debt instrument covenant payment percentage of net proceeds related to other assets constituting collateral					100.00%
Debt instrument, covenant description							(i) a maximum consolidated total leverage ratio, initially set at 7.25:1.00, decreasing over the term of the Amended FS/KKR Credit Agreement until reaching a final maximum ratio of 6.25:1.00 for the fiscal quarter ending September 30, 2022 and thereafter and (ii) a maximum consolidated first lien leverage ratio, initially set at 3.875:1.00, decreasing over the term of the Amended FS/KKR Credit Agreement until reaching a final maximum ratio of 2.875:1.00 for the fiscal quarter ending September 30, 2022 and thereafter
New Amended FS/KKR Credit Agreement [Member] | Scenario Plan One [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Consolidated first lien leverage ratio							3.875%
Final consolidated total leverage ratio							7.25%
New Amended FS/KKR Credit Agreement [Member] | Scenario Plan Two [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Consolidated first lien leverage ratio							2.875%
Final consolidated total leverage ratio							6.25%
New Amended FS/KKR Credit Agreement [Member] | Additional Loan Facility [Member] | Scenario Plan Three [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Consolidated total leverage ratio							6.00%
Third Amended BoA Credit Agreement [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Long-term debt										335,000,000
Amended BoA Revolving Credit Commitments [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Line of credit facility, maximum borrowing capacity										130,000,000
Line of credit facility, unused capacity, commitment fee percentage							0.375%
Consolidated first lien leverage ratio				3.875%
Final consolidated first lien leverage ratio				2.875%
Third Amended BoA Tranche A-1 Loans [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument, face amount										70,000,000
Long-term debt										70,000,000
Third Amended BoA Tranche A-1 Loans [Member] | London Interbank Offered Rate (LIBOR) [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument, basis spread on variable rate							7.00%
Third Amended BoA Tranche A-1 Loans [Member] | Base Rate [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument, basis spread on variable rate							6.00%
Amended BoA Revolving Loans and Amended Tranche A Loans [Member] | London Interbank Offered Rate (LIBOR) [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument, basis spread on variable rate							3.50%
Amended BoA Revolving Loans and Amended Tranche A Loans [Member] | Base Rate [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument, basis spread on variable rate							2.50%
Third Amended BoA Tranche A Loans [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument, face amount										150,000,000
Long-term debt										$ 150,000,000
New Amended BoA Credit Agreement [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Consolidated first lien leverage ratio							2.90%
Maximum | Tranche A [Member] | Scenario Plan One [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Consolidated first lien leverage ratio							2.80%
Maximum | Amended KKR Credit Agreement [Member] | Scenario Plan Two [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument consolidated total leverage ratio							4.00%
Maximum | Amended KKR Credit Agreement [Member] | Scenario Plan Three [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument consolidated total leverage ratio							3.00%
Maximum | Third Amended BoA Credit Agreement [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Maximum loan to value ratio				42.50%
Maximum | Third Amended BoA Tranche A-1 Loans [Member] | London Interbank Offered Rate (LIBOR) [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument, basis spread on variable rate				6.00%
Maximum | Third Amended BoA Tranche A-1 Loans [Member] | Base Rate [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument, basis spread on variable rate				5.00%
Maximum | Amended BoA Revolving Loans and Amended Tranche A Loans [Member] | London Interbank Offered Rate (LIBOR) [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument, basis spread on variable rate				3.00%
Maximum | Amended BoA Revolving Loans and Amended Tranche A Loans [Member] | Base Rate [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument, basis spread on variable rate				2.00%
Minimum [Member] | Tranche A -1 Term Loans [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Consolidated first lien leverage ratio							3.00%
Minimum [Member] | Amended KKR Credit Agreement [Member] | Scenario Plan One [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument consolidated total leverage ratio							4.00%
Minimum [Member] | Amended KKR Credit Agreement [Member] | Scenario Plan Three [Member]
Disclosure Long Term Debt Additional Information [Line Items]
Debt instrument consolidated total leverage ratio							3.00%

Long-Term Debt (Schedule of Lon

Long-Term Debt (Schedule of Long Term Debt) (Details) - USD ($) $ in Thousands	Sep. 30, 2019	Dec. 31, 2018	Jul. 01, 2016
Unamortized deferred financing costs	$ (22,608)	$ (24,063)
Total long-term debt, net of unamortized deferred financing costs	439,081	610,787
Less: current portion of long-term debt	21,000	28,300
Long term debt, noncurrent	418,081	582,487
BoA Term Loans [Member]
Secured Term Loans	456,331	519,850
Revolving Loans [Member]
Revolving Credit Facility	$ 5,358	$ 115,000
Total long-term debt, net of unamortized deferred financing costs			$ 115,000

Stock-based Compensation (Narra

Stock-based Compensation (Narrative) (Details) - USD ($)	Feb. 20, 2018	Sep. 30, 2019	Sep. 30, 2018	Jun. 30, 2016	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018
Warrants
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated share-based compensation expense		$ 0	$ 0		$ 0	$ 0
Unvested shares		0			0
Stock Appreciation Rights (SARs) [Member] | Employees and Consultants [Member] | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated share-based compensation expense					$ 100,000	700,000
Performance based restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated share-based compensation expense		$ 0	200,000		$ 200,000	800,000
Unvested shares		1,418,656			1,418,656		2,219,818
Performance based restricted stock | Years Ended December 31, 2016 - 2018 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated share-based compensation expense					$ 200,000
Number of shares vested					231,396
Performance based restricted stock | Employees and Consultants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated share-based compensation expense						500,000
Restricted stock awards, granted in period	208,883
Performance based restricted stock | Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted, Options					135,000
Grant date fair value of stock units granted					$ 300,000
Performance based restricted stock | Employees [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period					1 year
Performance based restricted stock | Employees [Member] | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period					2 years
Performance based restricted stock | Employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated share-based compensation expense			200,000			$ 200,000
Restricted stock awards, granted in period						200,000
Award vesting period						2 years
Shares issued under stock incentive plan (in shares)						83,250
Granted, Options						200,000
Grant date fair value of stock units granted						$ 500,000
Performance based restricted stock | Consultant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock awards, granted in period						250,000
Award vesting period						5 years
Grant date fair value of stock units granted						$ 500,000
Unvested restricted stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated share-based compensation expense		$ 100,000	100,000		$ 300,000	400,000
Unrecognized compensation expense, other than options		$ 300,000			$ 300,000
Unrecognized compensation expense, period for recognition					9 months 18 days
Restricted stock awards, granted in period					464,576
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value					$ 0.86
Unvested shares		522,269			522,269		292,989
Unvested restricted stock | Board of Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock granted, value, share-based compensation, gross					$ 400,000	400,000
Unvested restricted stock | Restricted Time-Based Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated share-based compensation expense		$ 100,000			200,000
Unvested restricted stock | Restricted Time-Based Units [Member] | Board of Directors [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated share-based compensation expense			100,000		$ 100,000	$ 200,000
Restricted stock awards, granted in period						235,296
Award vesting period				1 year
Restricted Stock Units (RSUs) [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unvested shares		1,001,371			1,001,371		1,615,953
Restricted Stock Units (RSUs) [Member] | Chief Financial Officer And Former Chief Financial Officer And Chief Executive Officer And Employees And Consultants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated share-based compensation expense					$ 700,000	$ 1,400,000
Unrecognized compensation expense, other than options		$ 900,000			$ 900,000
Unrecognized compensation expense, period for recognition					1 year 3 months 18 days
Restricted Stock Units (RSUs) [Member] | Chief Financial Officer And Former Chief Financial Officer And Chief Executive Officer And Employees And Consultants [Member] | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated share-based compensation expense		100,000	400,000
Restricted Stock Units (RSUs) [Member] | Employees and Consultants [Member] | Share-based Compensation Award, Tranche One [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated share-based compensation expense			200,000
Grant date fair value of stock units granted						$ 3,000,000
Restricted Stock Units (RSUs) [Member] | Employees and Consultants [Member] | Share-based Compensation Award, Tranche One [Member] | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Award vesting period						5 years
Restricted Stock Units (RSUs) [Member] | Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock awards, granted in period						1,635,257
Restricted Stock Units (RSUs) [Member] | Employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Restricted stock awards, granted in period						843,486
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Allocated share-based compensation expense		0	$ 0		$ 0	$ 0
Unrecognized compensation expense, options		$ 0			$ 0
Nonvested options		0			0
Warrants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense, other than options		$ 0			$ 0
Granted, Options

Stock-based Compensation (Summa

Stock-based Compensation (Summary of Stock Option Activity and Changes in Unvested Stock Options) (Detail) - Employee Stock Option [Member] - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding beginning, Number of Options	49,501
Forfeited or Canceled, Number of Options	(10,000)
Outstanding ending, Number of Options	39,501	49,501
Exercisable, Number of Options	39,501
Outstanding beginning, Weighted Average Exercise Price	$ 10.22
Forfeited or Canceled, Weighted Average Exercise Price	(13.68)
Outstanding ending, Weighted Average Exercise Price	9.34	$ 10.22
Exercisable, Weighted Average Exercise Price	$ 9.34
Weighted Average Remaining Contractual Life (in years)	2 years	2 years 3 months 18 days
Exercisable, Weighted Average Remaining Contractual Life (in years)	2 years
Nonvested
Outstanding ending, Number of Options	0

Stock-based Compensation (Sum_2

Stock-based Compensation (Summary of Warrant Activity) (Detail) - Warrants [Member] - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding beginning, Number of Options	200,000
Granted, Number of Options
Outstanding ending, Number of Options	200,000	200,000
Exercisable, Number of Options	200,000
Outstanding beginning, Weighted Average Exercise Price	$ 13.32
Granted, Weighted Average Exercise Price
Outstanding ending, Weighted Average Exercise Price	13.32	$ 13.32
Exercisable, Weighted Average Exercise Price	$ 13.32
Weighted Average Remaining Contractual Life (in years)	5 years 8 months 12 days	6 years 4 months 24 days
Exercisable, Weighted Average Remaining Contractual Life (in years)	5 years 8 months 12 days
Nonvested
Granted, Options

Stock-based Compensation (Sum_3

Stock-based Compensation (Summary of Restricted Stock Activity and Performance Stock Units) (Detail) - $ / shares	9 Months Ended	12 Months Ended
	Sep. 30, 2019	Dec. 31, 2018
Unvested restricted stock
Summary Of Restricted Stock Activity [Line Items]
Outstanding beginning, Other than options	292,989
Restricted stock awards, granted in period	464,576
Vested, Other than options	(235,296)
Outstanding ending, Other than options	522,269	292,989
Outstanding beginning, Weighted Average Exercise Price, Other than options	$ 3.72
Granted, Weighted Average Exercise Price, Other than options	0.86
Vested, Weighted Average Grant Date Fair Value	(1.70)
Outstanding ending , Weighted Average Exercise Price, Other than options	$ 0.85	$ 3.72
Nonvested, Weighted Average Remaining Vesting Period, Other Than Options, Nonvested	9 months 18 days	10 months 24 days
Performance based restricted stock
Summary Of Restricted Stock Activity [Line Items]
Outstanding beginning, Other than options	2,219,818
Vested, Other than options	(289,671)
Forfeited or Canceled, Other than options	(511,491)
Outstanding ending, Other than options	1,418,656	2,219,818
Outstanding beginning, Weighted Average Exercise Price, Other than options	$ 4.47
Vested, Weighted Average Grant Date Fair Value	(4.68)
Forfeited or Canceled, Weighted Average Exercise Price, Other than options	(6.59)
Outstanding ending , Weighted Average Exercise Price, Other than options	$ 3.66	$ 4.47
Nonvested, Weighted Average Remaining Vesting Period, Other Than Options, Nonvested	10 months 24 days	9 months 18 days
Restricted Stock Units (RSUs) [Member]
Summary Of Restricted Stock Activity [Line Items]
Outstanding beginning, Other than options	1,615,953
Vested, Other than options	(574,582)
Forfeited or Canceled, Other than options	(40,000)
Outstanding ending, Other than options	1,001,371	1,615,953
Outstanding beginning, Weighted Average Exercise Price, Other than options	$ 2.24
Vested, Weighted Average Grant Date Fair Value	(2.85)
Forfeited or Canceled, Weighted Average Exercise Price, Other than options	(1.76)
Outstanding ending , Weighted Average Exercise Price, Other than options	$ 1.25	$ 2.24
Nonvested, Weighted Average Remaining Vesting Period, Other Than Options, Nonvested	1 year 3 months 18 days	2 years 2 months 12 days

Related Party Transactions (Nar

Related Party Transactions (Narrative) (Details) - USD ($)	Jun. 10, 2019	Jul. 30, 2016	Dec. 04, 2015	Nov. 17, 2014	Jul. 30, 2013	Jan. 01, 2013	Sep. 30, 2015	Sep. 30, 2019	Sep. 30, 2018	Sep. 30, 2019	Sep. 30, 2018	Dec. 31, 2018	Aug. 15, 2014
Related Party [Line Items]
Revenue from Contract with Customer, Including Assessed Tax								$ 25,392,000	$ 29,455,000	$ 77,331,000	$ 92,044,000
Loss on sale of assets											(7,117,000)
Intangible asset agreement annual payment								1,700,000		1,700,000
Accounts Payable and Accrued Liabilities, Current								11,277,000		11,277,000		$ 11,600,000
Decrease (increase) in accounts payable and accrued liabilities										1,616,000	1,848,000
Decrease (increase) in other liabilities										4,410,000	(8,180,000)
TCP Agreement [Member]
Related Party [Line Items]
Cash Paid For Services								200,000	200,000	700,000	700,000
License agreement annual payment													$ 900,000
Acquisition of Transaction Fee										$ 1,800,000
FUL [Member]
Related Party [Line Items]
Loss on sale of assets												(2,000,000)
FUL [Member]
Related Party [Line Items]
Business combination, recognized identifiable assets acquired and liabilities assumed, intangible assets, other than goodwill				$ 8,900,000
Business acquisition, percentage of voting interests acquired				50.50%
Payments to acquire businesses, net of cash acquired				$ 4,500,000
Unvested restricted stock
Related Party [Line Items]
Other than options, granted										464,576
Tengram Capital Partners Gen2 Fund LP [Member]
Related Party [Line Items]
Percentage of beneficially owned outstanding common stock						5.00%
Tengram Capital Partners Gen2 Fund LP [Member] | TCP Agreement [Member]
Related Party [Line Items]
Amount due for services								200,000		$ 200,000		200,000
Tengram Capital Partners Limited Partnership [Member]
Related Party [Line Items]
Purchase price equity securities							$ 12,000,000
FUL IP [Member]
Related Party [Line Items]
Income (loss) attributable to noncontrolling interest								0		$ 0	$ 700,000
ES Originals Inc [Member]
Related Party [Line Items]
Type of Revenue										us-gaap:RoyaltyMember	us-gaap:RoyaltyMember
Revenue from Contract with Customer, Including Assessed Tax								1,200,000	3,100,000	$ 3,700,000	$ 6,600,000
Other asset								500,000		500,000		1,900,000
Due from related parties, current								4,800,000		4,800,000		6,200,000
Expenses, related party										200,000	200,000
TCP Employee [Member]
Related Party [Line Items]
Operating expenses								100,000	100,000	200,000	200,000
Due to related parties, current								0		$ 0
TCP Employee [Member] | Unvested restricted stock
Related Party [Line Items]
Other than options, granted					125,000
Award vesting period										4 years
TCP Employee [Member] | Performance based restricted stock
Related Party [Line Items]
Other than options, granted		200,000			180,000
Award vesting period										3 years
TCP Employee [Member] | Share-based Compensation Award, Tranche Two [Member] | Unvested restricted stock
Related Party [Line Items]
Other than options, granted										300,000
Award vesting period										3 years
Share based compensation, vesting percentage										25.00%
Centric Brands, Inc. [Member]
Related Party [Line Items]
Revenue from Contract with Customer, Including Assessed Tax								1,600,000		$ 4,800,000
Due from related parties, current								0		0
Current receivable												800,000
Accounts Payable and Accrued Liabilities, Current								500,000		$ 500,000
IP License Agreement and Intangible Asset Agreement [Member]
Related Party [Line Items]
Terms of agreement, description										for calendar years 2018 through 2020 exceed $195 million or the gross licensing revenues for calendar year 2020 equal or exceed $65 million.
Aggregate gross revenues per agreement, benchmark			$ 195,000,000
Gross revenues per agreement, benchmark			$ 65,000,000
License agreement payments during period										$ 800,000	300,000
Accretion expense									100,000	100,000	300,000
Decrease (increase) in accounts payable and accrued liabilities	$ 2,800,000
Decrease (increase) in other liabilities	$ 1,100,000
IP License Agreement [Member]
Related Party [Line Items]
License agreement annual payment								1,300,000		1,300,000
License agreement payments during period									300,000	600,000	1,000,000
Tommie Copper, Incorporated [Member]
Related Party [Line Items]
Revenue from Contract with Customer, Including Assessed Tax											$ 3,100,000
Due from related parties, current								100,000		$ 100,000		1,100,000
Due from related parties, noncurrent												1,900,000
Account receivable written off								2,700,000
Award Date One [Member] | TCP Employee [Member] | Share-based Compensation Award, Tranche One [Member] | Performance based restricted stock
Related Party [Line Items]
Share based compensation, vesting percentage										20.00%
Award Date One [Member] | TCP Employee [Member] | Share-based Compensation Award, Tranche Two [Member] | Performance based restricted stock
Related Party [Line Items]
Share based compensation, vesting percentage										20.00%
Award Date One [Member] | TCP Employee [Member] | Share-based Compensation Award, Tranche Three [Member] | Performance based restricted stock
Related Party [Line Items]
Share based compensation, vesting percentage										60.00%
Award Date Two [Member] | TCP Employee [Member] | Share-based Compensation Award, Tranche One [Member] | Performance based restricted stock
Related Party [Line Items]
Share based compensation, vesting percentage										33.30%
Award Date Two [Member] | TCP Employee [Member] | Share-based Compensation Award, Tranche Two [Member] | Performance based restricted stock
Related Party [Line Items]
Share based compensation, vesting percentage										33.30%
Award Date Two [Member] | TCP Employee [Member] | Share-based Compensation Award, Tranche Three [Member] | Unvested restricted stock
Related Party [Line Items]
Other than options, granted										150,000
Award Date Two [Member] | TCP Employee [Member] | Share-based Compensation Award, Tranche Three [Member] | Performance based restricted stock
Related Party [Line Items]
Share based compensation, vesting percentage										33.40%
Maximum | ES Originals Inc [Member]
Related Party [Line Items]
Expenses, related party								$ 100,000	100,000
Maximum | TCP Employee [Member]
Related Party [Line Items]
Due to related parties, current												$ 100,000
Maximum | IP License Agreement and Intangible Asset Agreement [Member]
Related Party [Line Items]
License agreement payments during period									$ 100,000

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event - Avia trademark - USD ($) $ in Millions	Oct. 24, 2019	Jun. 30, 2022	Jun. 30, 2021	Jun. 30, 2020
Subsequent Event [Line Items]
Contract price	$ 12.3
Instalments period	3 years
Payment receivables		$ 4	$ 5	$ 3.3